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ABSTRACT 
Despite considerable evidence to support efficacious and effective intervention 
for single health behaviors, relatively little is known about simultaneous multiple health 
behavior change.  This research analyzed multiple health behavior change for three very 
different health risk behaviors.  The sample (N=9,461) was predominantly White 
(93.8%), middle-aged (X= 43.9 years-old, SD=10.74) adults who met criteria for 
smoking, unhealthy diet, and unprotected sun exposure.  Specifically, when sun 
protection and diet, smoking and diet, and smoking and sun protection were analyzed as 
three sets of behavior pairs from baseline to 24-month follow-up, results consistently 
demonstrated that simultaneous intervention on multiple health behavior risks increased 
the likelihood that participants moved to criteria on both behaviors.  More specifically, 
across all the behavior pair analyses and treatment conditions, 70 out of the 71 odds ratios 
revealed that participants were more likely to meet criteria on both behaviors compared 
to participants who only met criteria on the second behavior.  Overall, results provide 
empirical support for the advantages of simultaneous intervention for multiple health 
behavior change as paired action, co-progression, and reduction on severity was observed 
across treatment conditions.  Finally, results provide empirical support for shifting the 
fundamental unit of analysis from separate behaviors at outcome to behavior pairs at 
outcome and to use dynamic variables to help elucidate the science of behavior change.  
  
 iii 
 
ACKNOWLEDGMENTS 
Data used for this project were drawn from a National Cancer Institute (NCI)-
funded grant (P01; #CA27821, Principle Investigator, Prochaska) that assessed the 
effectiveness of home, school, worksite, and medical practice-based prevention programs 
designed to reduce multiple behavior risks for cancer.  I would like to thank Dr. James 
Prochaska for providing me with access to the dataset and for supporting this project.  I 
would like to thank Dr. Andrea Paiva, my major professor, for her continued guidance 
and unwavering support throughout this project.  Additionally, I would like to thank Drs. 
Joseph Rossi, Mark Robbins, Barbara Newman, and Jacqueline Sparks, the rest of my 
dissertation committee, whose contribution to this project and my professional 
development has been equally invaluable.   
I would also like to express my deepest gratitude to my wife, family, and friends 
whose love and loyalty through the years provided the support so I could achieve my 
goals.  Above all else, I would like to thank my late mother, Joyce Spas, whose diligence, 
selflessness, and unconditional love provided the opportunity and inspiration for me to 
pursue my dreams, and upon whose shoulders I continue to stand.   
Finally, as a secondary data analysis that did not access participant personal 
health information (PHI), the Institutional Review Board (IRB) granted this project an 
exemption.  All statistical procedures were conducted with SPSS, and all literature was 
accessed through the URI library reference databases.  
 
 iv 
 
TABLE OF CONTENTS 
               Page 
ABSTRACT………………………………………………………………………………ii 
 
ACKNOWLEDGMENTS…...…………………………………………………………...iii 
 
TABLE OF CONTENTS…….…………………………………………………………...iv 
 
LIST OF TABLES……………….………………………………………………..............v 
 
CHAPTER 1           
 INTRODUCTION………………………………………………………..............1 
 
CHAPTER 2          
 REVIEW OF LITERATURE…………………………………………………….3   
 
CHAPTER 3        
 METHODOLOGY………………………………………………………………17 
 PARTICIPANTS & MEASURES……………………………………………….18 
 DATA ANALYTIC STRATEGIES……………………………………………..22 
 
CHAPTER 4           
 FINDINGS          
 HYPOTHESIS 1…………………………………………………………………32 
 HYPOTHESIS 2…………………………………………………………………37 
 HYPOTHESIS 3…………………………………………………………………41 
 HYPOTHESIS 4…………………………………………………………………45 
 HYPOTHESIS 5…………………………………………………………………49 
 HYPOTHESIS 6…………………………………………………………………52 
 
CHAPTER 5 
 CONCLUSIONS………………………………………………………...............69 
 LIMITATIONS…………………………………………………………………..76 
 SUMMARY……………………………………………………………………...79 
 
APPENDIX…….………………………………………………………………...............81 
 
BIBLIOGRAPHY………………………………………………………………………..82 
 
 v 
 
LIST OF TABLES 
                                                     PAGE 
1. Decisional Balance, Self-Efficacy, & Problem Severity: Sun, Diet, & Sun Exposure  21     
2. Demographics and descriptive statistics for total sample, baseline-24 mos                  35         
3. Paired action: PC or C/PR at baseline and A/M on both behaviors at 24 mos              36             
4. Co-progression rates for stage progress with behavior pairs, baseline-24 mos             40                                         
5. Co-progression rates for reduction in severity with behavior pairs, baseline-24 mos   44         
6. Co-progression rates for .4 SD Pros increase for behavior pairs, baseline-24 mos       48         
7. Co-progression rates for stage progress with behavior pairs by race                            54 
 
8. Co-progression rates for stage progress with behavior pairs by gender                        56 
 
9. Co-progression rates for reduction in severity with behavior pairs by race                  59 
10. Co-progression rates for reduction in severity with behavior pairs by gender            62 
11. Co-progression rates for increasing Pros .4 SD with behavior pair by race                65        
 
12. Co-progression rates for increasing Pros .4 SD with behavior pairs by gender          68      
 1 
 
CHAPTER 1 
INTRODUCTION 
Although research has advanced clinical science in some areas, other areas 
continue to lag.  For example, despite considerable evidence to support efficacious and 
effective intervention for single health behaviors, relatively little is known about multiple 
health behavior change.  Moreover, simultaneous intervention on multiple health 
behavior risks challenges the dominant separate behavior paradigm which evaluates 
interventions based on single behavior outcomes as the fundamental unit of analysis in 
order to establish intervention efficacy and effectiveness.   
In response to the growing demands for more rigorous evaluation of intervention 
efficacy, effectiveness, and cost efficiency, multiple health behavior change holds 
considerable promise for the future of intervention and prevention research and practice.  
Moreover, multiple health behavior change is important because certain populations are 
among the greatest risk for chronic disease, disability, and premature death (Prochaska, 
2008) and because of the increased prevalence of obesity and sedentary lifestyles in the 
United States.  So, although behavioral interventions have long demonstrated to be 
critical, cross-cultural, and cost-effective factors germane to the development and 
prevention of numerous medical conditions including cardiovascular disease and some 
cancers, it remains unclear how simultaneous intervention on multiple health behavior 
risks fares when the fundamental unit of analysis is shifted from separate behaviors at 
outcome to behavior pairs at outcome.  Such a shift is important because doing so may 
reveal synergistic effects currently undetected by the dominant separate behavior 
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paradigm and its analytic approaches, in addition to advancing the knowledge-base and 
scientific evaluation of behavioral interventions for multiple health behavior change.   
Given the direct and considerable impact of health risks on mortality, quality of 
life, and health care costs, in combination with the cutting edge research on multiple 
health behavior change, the following research is important because it serves to: 1) 
promote population-based health and wellness; 2) understand the underlying mechanisms 
and interrelationships of effective intervention for multiple health behavior change; and 
3) help elucidate the science of behavior change.  Moreover, this research will advance 
the current knowledge-base in intervention and prevention research, possibly provide an 
empirical basis to shift the dominant separate behavior paradigm, and help guide the 
future of intervention and prevention research and practice toward an integrative model 
of multiple health behavior change.  
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CHAPTER 2 
REVIEW OF LITERATURE 
Intervention is a broad enterprise replete with myriad aims and goals.  Although 
specification of a treatment and evaluation of its feasibility and efficacy are of central 
importance (Kazdin, 2003), equally important are considerations about its’ effectiveness, 
cost-efficiency, and potential for iatrogenic effects.  Considered together, these distinct 
aims can be coalesced into a larger, more comprehensive analysis known as treatment 
evaluation (Nelson & Steele, 2006).  This framework is not only part of the impetus 
behind the evidenced-based practice (EBP) movement in psychology, but also part of the 
larger scientific zeitgeist calling for more precise and methodologically rigorous research.  
Toward that aim, the Transtheoretical Model (TTM) (Prochaska & DiClemente, 1983) 
has emerged as an important advancement in behavioral intervention by establishing 
strong empirical support for effectively intervening on more than 48 problem behavioral 
areas by providing individually and expertly tailored, stage-based interventions based on 
an individual’s stage of change (Hall & Rossi, 2008). 
 The TTM is an integrative model of intentional behavior change centrally 
organized around the temporal Stage of Change (SOC) dimension (Prochaska & 
DiClemente, 1983).  Specifically, the TTM is comprised of five stages of change: 
Precontemplation (i.e., PC- not intending to take action in the next six months), 
Contemplation (i.e., C- intending to action in the next 6 months), Preparation (i.e., PR- 
intending to take action in the next thirty days), Action, (i.e., A- there has been an overt 
behavior change which has not been maintained for six months), and Maintenance (i.e., 
M- a behavior change has been maintained for at least six months).  Essentially, SOC 
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describe the processes through which behavior change occurs in individuals or 
populations (e.g., smokers) over time.  Critical to behavior change is that movement 
through the SOC varies as some people remain in a certain SOC for a period of time 
while others may relapse to earlier stages before behavioral change goals are met 
(Prochaska, Redding & Evers, 2008).  In addition to SOC, there are several other 
constructs central to the TTM. 
 Decisional Balance (DB) is the construct that refers to the Pros and Cons of 
behavior change (Velicer, DiClemente, Prochaska & Brandenberg, 1985).  Specifically, 
this construct refers to an individual’s perception about the relative weights about making 
behavior change (Velicer et al, 1985); the benefits of a behavior change are labeled Pros, 
whereas the costs of a behavior change are labeled Cons.  For example, a Pro of quitting 
smoking may be reduced cancer risk or saving money, whereas a Con may be concerns of 
weight gain or experiencing nicotine withdrawal symptoms.  DB is important as it has 
been shown to be particularly useful in predicting movement through the SOC 
(Prochaska, Velicer & Rossi, 1994), and because the relationship between the Pros and 
Cons has been replicated across 48 problem areas (Hall & Rossi, 2008).  An outgrowth of 
this consistent pattern across multiple problem areas is referred to as the strong and weak 
principles (Prochaska, 1994).  The former states that progression from PC to A is a 
function of approximately one standard deviation increase in the Pros of a health 
behavior change, while the latter states that progression from PC to A is a function of 
approximately a half standard deviation decrease in the Cons of a health behavior change.  
Although this relationship has been replicated across a variety of single behaviors, little is 
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known about the relationship between DB and simultaneous multiple health behavior 
change.  
 Self-Efficacy (SE) is the construct that refers to the situation specific confidence 
an individual has to cope with high risk situations or temptations (Velicer, DiClemente, 
Rossi & Prochaska, 1990).  Similar to DB, SE has been shown to be particularly 
important to predicting movement through the SOC.  Specifically, Velicer, DiClemente, 
Rossi & Prochaska (1990) found that individuals in earlier SOC (i.e., PC/C) typically 
report lower confidence in a behavior change as compared to those individuals who are in 
later SOC (i.e., A/M).  This finding suggests that an individual’s SE increases as the 
individual progresses through the TTM.  However, with regard to multiple health 
behavior change specifically, little is known whether increasing an individual’s SE on 
one behavior leads to an increase in the individual’s SE on a second behavior.  Thus, 
although the TTM has established efficacy and effectiveness for intervening on numerous 
single health behaviors (e.g., smoking cessation, diet, unprotected sun exposure), little is 
known whether and how TTM intervention affects multiple health behavior change 
simultaneously.  
 Processes of Change (POC) is the construct that refers to the covert and overt 
strategies and techniques people use to alter their experiences and environment to 
progress through the various SOC (Prochaska, Velicer, DiClemente & Fava, 1988).  By 
integrating various theoretical orientations (e.g., psychodynamic, social-learning), the 
TTM has derived ten POC comprised of two higher order constructs that are either 
experiential or behavioral in nature.  The five experiential processes are: Consciousness 
Raising, Dramatic Relief, Social Liberation, Self-reevaluation, and Environmental 
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Reevaluation (Prochaska, Velicer, DiClemente & Fava, 1988).  The five behavioral 
processes are: Stimulus Control, Helping Relationships, Reinforcement Management, 
Self-liberation, and Counter Conditioning (Prochaska, Velicer, DiClemente & Fava, 
1988).  Interestingly, Prochaska, Velicer, DiClemente, Guadagnoli, & Rossi (1991) found 
that the use of each POC was highly related to an individual’s SOC.  Specifically, they 
found that experiential POC (e.g., Consciousness Raising) were emphasized at earlier 
SOC (i.e., PC/C), whereas behavioral POC (e.g., Helping Relationships) were 
emphasized at later SOC (i.e., A/M).  With regard to multiple health behavior change, 
however, little is known about how movement through the SOC on one behavior is 
related to movement through the SOC on a second behavior.   
For example, do smokers who make stage progress toward smoking cessation 
(i.e., PC-C or C-PR) but not to Action criteria also make stage progress on other health 
behaviors associated with improved health outcomes such as diet, exercise, or 
unprotected sun exposure?  Or, is it that individuals remain stable or possibly regress to 
an earlier SOC on a different problem area because of the difficulty associated with 
behavior change?  In addition to these important yet unanswered questions, research has 
revealed how issues of multiculturalism and diversity are also essential considerations 
when evaluating stage and population-based behavioral intervention for health behavior 
risks.  Specifically, research has shown that diverse groups have different baseline 
staging for various health behaviors.  In addition, research has also revealed that certain 
groups are at more risk than other groups to engage in multiple health behavior risks.  
Given these findings, group membership with regard to sex, gender, age, race, sexual 
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orientation, and religious affiliation are important factors when assessing and intervening 
with stage-based behavioral intervention.   
Blum et al. (2001) found that White adolescents were more likely to smoke 
cigarettes, drink alcohol, and attempt suicide in younger years than Black and Hispanic 
youth, but that Black youths were more likely to engage in sexual intercourse while 
Black and Hispanic youths were both more likely than White adolescents to engage in 
violence.  When considering sexual orientation and adolescents, Garofalo, Wolf, Kessel, 
Paslfrey, & DuRant (1998) found that gay, lesbian, and bisexual (GLB) youth were more 
likely than their peers to have been victimized and threatened and to have engaged in a 
variety of health risk behaviors including suicidal ideation and attempts, multiple 
substance use, and sexual risk behaviors.   
In a 30-year longitudinal study on religious affiliation and health behaviors, 
Strawbridge, Shema, Cohen, & Kaplan (2001) found that weekly religious attendance 
reduced severity on health risk behaviors and helped maintain good health behaviors, 
while also improving and maintaining good mental health, increased social relationships, 
and marital stability with stronger effects for women than men.  Similarly, and specific to 
sex and gender differences for sunscreen use and diet, Weinstock, Rossi, Redding, 
Maddock & Cottrill (2001) found women were more likely than men to engage in sun 
protective behaviors, while Campbell et al. (1999) found that women more likely than 
men to be in the Action/Maintenance (i.e., A/M) stage for fruit and vegetable 
consumption. 
With respect to independent baseline predictors and group-level patterns of 
alcohol use, Brennan, Schutte, & Moos (2010) found that although males tend to have 
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and maintain more problems associated with alcohol consumption than females across 
the lifespan, the single strongest predictor of 10-year drinking trajectories was baseline 
alcohol consumption in excess of recommended drinking guidelines for older adults, 
regardless of sex, gender, race, or socioeconomic status.  Furthermore, these findings are 
consistent with previous research that revealed heavier initial drinking predicts steeper 
decline in subsequent alcohol use in both mixed-aged and older populations (Kerr et al., 
2004; Moore et al. 2005).    
Despite the importance of demographic variables such as race, ethnicity, gender, 
age, socioeconomic status and education level on baseline staging, demographic variables 
have not been shown to be reliable predictors of treatment outcome.  For example, with 
smoking outcomes across five studies, Velicer, Redding, Sun, & Prochaska (2007) found 
no significant differences across gender, race, and ethnicity; however, they did find a few 
significant findings and small effect sizes for age and education subgroups.  Similarly, 
with smokers, Redding et al. (2011) also found that behavior changes were not 
consistently related to demographic variables and group membership.  Instead, they 
found significant small-to-medium-sized differences between stable smokers from 
maintainers/relapsers based on baseline SOC, problem severity, and effort.  Overall, the 
consistent finding that gender is not a significant variable for smoking cessation was part 
of the Surgeon General’s Report (U.S. Department of Health & Human Services, 2011) 
concluding that, “cessation interventions are generally of similar effectiveness to women 
and men and, to date, few gender differences have been identified” (p. 8). 
With regard to race, ethnicity, and smoking cessation, Velicer et al. (2007) found 
a lack of significant relationships between these baseline variables and treatment 
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outcome.  Specifically, with effect sizes were near zero for race and small effect sizes for 
ethnicity, they concluded that tailored behavioral intervention is about equally effective 
across racial and ethnic subgroups.  Research in addictions has further shown that 
problem severity such as time to first cigarette in the day (i.e., Fagerstrom’s Index) is 
inversely related to success across demographics (Falba, Jofre-Bonet, Busch, Duchovney, 
& Sindalar, 2004).  Including demographic variables other than gender, race, and 
ethnicity, Sheeran’s (2002) meta-analysis across multiple health behaviors confirmed that 
intention to change (i.e., SOC in TTM) is vital to promoting change, but that intention 
alone is insufficient to predict outcome as only 47 percent of those with positive intention 
to take Action on a behavior actually did take Action; that is, move to healthy criteria.       
When specifically analyzing smoking, diet, and unprotected sun exposure, 
Blissmer et al. (2010) also found that demographic variables were not reliable predictors 
of treatment outcome.  However, what they did find is that four effects do reliably predict 
treatment outcome.  Specifically, as measured by decisional balance (DB), processes of 
change (POC), and self-efficacy (SE), Blissmer et al. (2010) found that 1) treatment, 2) 
baseline SOC, 3) addiction severity, and 4) effort all predicted treatment outcome during 
multiple health behavior change.  Interestingly, the largest effect sizes were observed 
with the SOC, followed by SE, treatment, and effort, respectively.  Similar to previous 
findings, they also found that demographic variables had the smallest effect sizes.  
Ultimately, this suggests that static variables at baseline such as demographics do not 
predict treatment outcome and, in contrast, that dynamic variables do predict treatment 
outcome.  Therefore, the dynamic variables of SOC, DB, and problem severity are 
important when investigating multiple health behavior change as they have been shown 
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to be among the best predictors of treatment outcome.  Moreover, these findings further 
suggest that dynamic variables are among the most salient factors relevant to health 
behavior change and that, perhaps, they are among the most important variables to help 
elucidate the science of multiple health behavior change.   
Given the intricacies of behavior change, and some of the inherent difficulties 
with behavioral health research, the dominant paradigm of intervention and prevention 
research has been to intervene on a problem area by first establishing a baseline criteria, 
then measure that behavior at intervention outcome and, ideally, at some follow-up time 
point.  A natural and logical outgrowth of this approach has been, historically, for 
interventions to report outcome criteria on separate behaviors in order to establish 
intervention efficacy and effectiveness, independent from its possible effect on other 
problem areas.  For example, smoking cessation interventions are considered efficacious 
(i.e., internal validity) if and only if the intervention leads to the individual meeting an 
abstinence criterion for smoking at outcome and at some follow-up time point.  
Conversely, interventions are considered to lack efficacy if they do not lead to an 
individual meeting the abstinence criterion at whether at outcome or at follow-up.   
 In contrast to abstinence-based outcomes, motivational interviewing (MI; Miller 
& Rollnick, 1995; 2002) and other harm reduction models have emerged to show that 
although individuals may not meet a stringent abstinence criterion on a problem area 
(e.g., alcohol), interventions that reduce behavioral risks are nonetheless clinically useful 
and help accelerate individuals toward reduced risk and healthier outcomes.  
Additionally, and similar to finding with the TTM, MI has also demonstrated that certain 
changes within individuals during an intervention can predict their behavior change at 
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future time points.  For example, Baer et al. (2008) demonstrated how client change talk 
(i.e., CT) during brief, 15-minute MI interviews can significantly and prospectively 
predict behavioral changes in substance use at 1 and 3-month follow-up.   
Amrhein et al. (2003) demonstrated how commitment strength (CS), defined as 
desire, readiness, and reasons to change, during intervention can predict reduced 
substance use at 3 and 6-month follow-up.  In their analyses, they also identified three 
specific patterns of substance abuse users: maintainers, changers, and strugglers.  In 
Amrhein et al.’s research, maintainers referred to those participants who remained active 
users, changers were those participants who took action toward cessation or reduced use, 
and strugglers were those participants who frequently relapsed; similar to the pattern 
found in the Redding et al. study.  Although MI has demonstrated efficacy and 
effectiveness for severity reduction and behavior change for a variety of substance abuse 
and addictive behaviors (e.g., alcohol), particularly for resistant individuals (i.e., PC in 
the TTM), MI has also has targeted separate behaviors and analyzed separate behaviors 
as the fundamental unit of analysis.  Therefore, despite MI helping to advance the 
literature for health behavior risks and single behavior change, it has not advanced 
multiple health behavior change.  So, despite its many advances and contributions, MI is 
also limited in its empirical contribution to this area. 
 Multiple health behavior change is critical as certain populations are among the 
greatest risk for chronic disease, disability, and premature death (Prochaska, 2008).  
Among tobacco users, for example, it is estimated that approximately 92% also meet 
criteria for at least one additional risk behavior such as heavy alcohol drinking, physical 
inactivity, or low consumption of fruits and vegetables (Pronk et al., 2004; Klesges, Eck, 
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Isbell, Fulliton & Hanson, 1990).  However, with over 6,000 studies on smoking 
cessation (Fiore, 2000), there remains a paucity of research that evaluates intervention for 
simultaneous multiple health behavior change despite the well established association 
between health behavior risks and other problem areas.  Taken together, although there is 
considerable and compelling research on behavioral intervention for smoking, diet, and 
unprotected sun exposure as separate behaviors, there are many notable gaps in the 
literature for simultaneous intervention on multiple health behavior risks.  This is 
important because smoking, diet, and unprotected sun exposure are not only the most 
prominent lifestyle factors associated with cardiovascular disease, diabetes, and some 
cancers, they are also among the top causes of preventable deaths in the United States.   
 Given the growing need for multiple health behavior change, research has 
recently started to address the efficacy and effectiveness of behavioral interventions 
designed to simultaneously change two or more targeted health behavior risks 
(Prochaska, 2008).  That is, research has recently shifted toward understanding the 
particular interrelationships among health behaviors and the interventions designed to 
promote change in more than one health behavior risk simultaneously (Prochaska, 
Spring, & Nigg, 2008).  Toward this end, Paiva (2012) recently defined co-action of 
behavior change as the extent to which change on one behavior is associated with change 
on a second behavior at the same follow-up time point.  With multiple health behavior 
change specifically, Paiva et al. (2012) found that individuals in the treatment condition 
who progressed to Action/Maintenance on one behavior were more likely to progress on 
a second behavior compared to those participants in the same treatment condition group 
who did not move to Action/Maintenance on the first behavior.  These preliminary 
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findings are important as they begin to explore the intricacies of simultaneous change of 
multiple health behaviors, but additional research is necessary to further refine the current 
knowledge base.   
At present, the science of multiple health behavior change is in its nascent stages.  
As such, many important questions remain unclear or unanswered.  For example, how 
exactly does effective change on one behavior affect change on a second behavior?  If 
individuals take Action on one behavior, is this related to taking effective Action on a 
second behavior (i.e., co-action), do they progress toward Action on both behaviors (i.e., 
paired action), do they make stage progress toward Action but do not meet Action criteria 
(i.e., co-progression), or do they remain stable, or possibly even regress to earlier stages 
of change?  Ultimately, because these questions all aim to identify and elucidate the 
interrelationships among behavior change, co-variation can be used to describe the 
broader construct of co-action, paired action, and co-progression.  Specifically, co-
variation may be considered the broader construct as co-action, paired action, and co-
progression may well be conceptualized as three different types of co-variation.  
However, given the specific definitions for co-action, paired action, and co-progression in 
the literature, this research will adhere to the definitions provided in the literature and 
define movement to Action criteria on a second behavior as co-action (Paiva, 2012), and 
define stage progress, increases on DB, and reduced severity as co-progression. 
Additionally, it is not clear whether there are any synergistic effects during 
multiple health behavior change and, if so, whether these effects are specific to the 
treatment condition or if they naturally occur in the control condition as a natural 
outgrowth of multiple health behavior change.  Moreover, it remains unclear whether and 
 14 
 
how multiple health behavior change may vary by different behavior pairs.  For example, 
it is possible that there are differences when addictive behaviors (e.g., smoking) are 
paired together with non-addictive behaviors (i.e., unprotected sun exposure, exercise).  
Finally, it also remains unclear how paired action (i.e., changes in both behaviors of a 
pair), singular action (i.e., change in only a single behavior of a pair), and total action 
(i.e., changes in a full set of behaviors that is expected to produce synergy with the 
changes in untreated behaviors but only when a tipping point is reached in terms of the 
magnitude of change in treated behaviors per participant) (Prochaska et al., 2011) relates 
to multiple health behavior change when the fundamental unit of analysis is changed 
from separate behaviors at follow-up to behavior pairs at follow-up.   
The consistent findings with SOC, DB, problem severity (e.g., dynamic variables) 
and treatment outcome for separate behaviors has lent considerable support to the TTM’s 
focus on stage and stage progress particularly during the initial phase of intervention 
(Velicer et al., 2007).  However, relatively little is known about the interrelationships of 
the dynamic variables and multiple health behavior change.  Therefore, even less is 
known about how defining success as: 1) movement to A/M on both behaviors, 2) 
reduction on severity on both behaviors, or 3) accelerating participants through the SOC 
on both behaviors may affect and predict treatment outcomes.    
The justification for this study’s hypotheses is based on the TTM’s definition of 
change as stage progress and success as progressing to A/M criteria, the phenomenon of 
co-action and co-progression, the consistent findings that dynamic (i.e., not static) 
variables reliably predict treatment outcome, as well as the clinical value and utility of 
severity reduction on health risk behaviors.  Specifically, investigating paired action and 
 15 
 
co-progression to reveal how SOC, DB, and problem severity affect multiple health 
behavior change is important because these dynamic variables have proven to be among 
the best predictors of treatment outcome within the paradigm of separate behavior 
change.  Therefore, investigating how baseline SOC, the Pros and Cons of behavior 
change (i.e., DB), and problem severity relates to multiple health behavior is especially 
important in order to help establish an empirical basis to answer existing questions and 
guide future research.  Finally, these hypotheses may also help guide the future of 
behavioral health intervention and prevention research to shift from the dominant 
paradigm of separate behavior change and embrace an integrative model of multiple 
health behavior change.  
The specific hypotheses for this project are: 
 H1) Participants in Contemplation (C) or Preparation (PR) at baseline for two 
behaviors will be more likely to move to criteria (Action/Maintenance) on both behaviors 
at final follow-up (i.e., paired action) than participants who are in Precontemplation (PC) 
at baseline for both behaviors. 
 H2) Participants who make stage progress (i.e., progress at least one stage) on one 
behavior will also make stage progress on a second behavior, with more co-progression 
observed in the treatment than the control group. 
 H3) Participants who decrease their severity by a defined amount on one behavior 
will also decrease their severity on a second behavior, with more co-progression observed 
in the treatment than the control group. 
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 H4) Participants who increase their Pros and Cons by a defined amount on one 
behavior will do the same for a second behavior, with more co-progression observed in 
the treatment than the control group. 
 H5) As an exploratory approach, it is expected that participants who move to 
Action/Maintenance on only one behavior will also show smaller signs of success as 
defined by: a) making stage progress on a second behavior, b) decreasing severity on a 
second behavior; and c) increasing their Pros and decreasing their Cons on a second 
behavior.  It is also expected that these changes will be observed in the treatment group 
more than in the control group.  
 H6) Paired action and co-progression are not expected to vary by race or gender. 
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CHAPTER 3 
METHODOLOGY 
This research was a secondary data analysis that investigated multiple health 
behavior change, co-action, paired action, and co-progression using the Transtheoretical 
Model.  Data used for this project were drawn from a National Cancer Institute (NCI)-
funded center grant (P01; CA27821, Principle Investigator, Prochaska) that assessed the 
effectiveness of home, school, worksite, and medical practice-based prevention programs 
designed to reduce multiple behavior risks for cancer.  Specifically, this P01 evaluated 
the effectiveness of stage-matched, interactive, computer-tailored intervention (CTI) 
designed to accelerate individuals through each of the five Stages of Change (SOC) for 
multiple health risk behaviors: diet (i.e., high fat and low fiber diets), unprotected sun 
exposure, smoking, sedentary lifestyle, and adherence to breast cancer screening 
recommendations over a five-year period with several assessment time points.  
Additional details of this grant including, but not limited to, primary and secondary aims, 
inclusion and exclusion criteria for participants, measures, and continuous IRB approval 
are available for further review.  The following research project includes analyses on the 
health behavior risks of smoking, diet, and unprotected sun exposure and, specifically, 
analyzes the behavior pairs: sun protection and diet, smoking and diet, and smoking and 
sun protection. 
The primary aim of this research was to elucidate multiple health behavior change 
during stage-based, interactive and computer-tailored intervention (CTI) for multiple 
health risk behaviors with the goal of broadening the phenomenon of co-action to include 
a series of smaller changes deemed clinically important.  Specifically, this study analyzed 
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the behavior pairs 1) sun protection and diet, 2) smoking and diet, and 3) smoking and 
sun protection to reveal paired action and co-progression rates in order to answer some of 
the important, yet unanswered, questions about multiple health behavior change. 
There were also several secondary aims of this study.  First, this study was 
designed to help promote population health and wellness by advancing the knowledge 
base about intervention efficacy and multiple health behavior change by targeting a few 
of the most prominent lifestyles risk factors (e.g., smoking, diet, unprotected sun 
exposure) associated with preventable deaths in the United States including 
cardiovascular disease and some cancers (e.g., lung).  Second, this study was designed to 
help elucidate the science of behavior change by revealing how the Stages of Change 
(SOC) and the mathematical relationship of decisional balance (DB) relates to multiple 
health behavior change.  Third, this study aimed to provide an empirical basis to possibly 
shift the dominant separate behavior paradigm and, in so doing, help guide the future of 
intervention and prevention research and practice toward an integrative model of multiple 
health behavior change.      
Participants 
Participants of the study were adults in the United States proactively recruited by 
telephone.  Upon telephone contact, prospective participants were screened in order to 
satisfy explicit inclusionary criteria and be sure they did not meet exclusionary criteria.  
The sample (N=9,461) was comprised of parents of adolescents who were participants in 
a school-based study, patients from a health insurance provider, and employees from 22 
identified worksites.  Participants were predominantly middle-aged (X= 43.9 years-old, 
SD=10.74), White (93.8%), and female (65.4%).  All participants were assessed at 
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baseline and at 6-month intervals through 30 months post-intervention.  Additional 
details on the inclusion and exclusion criteria as well as the specific Procedures for each 
project within the P01 were determined by each principle investigator (PI) and are 
available on the original grant.  
Measures: 
Demographics:  
Single items were used to assess age, gender, education, ethnicity, marital status 
and perceived general health.    
Stage of Change: 
Smoking: SOC was measured by a staging algorithm that assessed participants’ 
readiness to quit smoking with response options of 1=Precontemplation (i.e., PC- not 
intending to quit smoking in the next six months), 2=Contemplation (i.e., C- intending to 
quit smoking in the next six months), 3=Preparation (i.e., PR- intending to quit smoking 
in the next thirty days), 4=Action, (i.e., A- quit smoking less than six months ago), and 
5=Maintenance (i.e., M- quit smoking more than six months ago). 
Diet: SOC was assessed in a 3-step process.  First, intention was assessed by the 
following question, “Do you consistently avoid eating high-fat foods?”  Subjects 
responding “No” were assigned to either: a) Precontemplation– “No, and I do not intend 
to in the next 6 months”; b) Contemplation– “No, but I intend to in the next 6 months; or 
c) Preparation– “No, but I intend to in the next 30 days.”  Second, subjects responding 
“Yes,” must have met a behavioral criterion of estimated fat intake ≤ 30% calories (based 
on the Dietary Behavior Questionnaire) to be classified into Action– "Yes, but for less 
than 6 months" or Maintenance– "Yes, for more than 6 months."  Third, subjects who 
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perceived that they consistently avoid high fat foods, but fail to meet the behavioral 
criterion were classified into Precontemplation, Contemplation, or Preparation based on 
intention to change eating habits (Greene et al., 1999). 
Sun Exposure: 
Decisional Balance, Self-Efficacy, and Problem Severity: Table 1.  
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Table 1: Decisional Balance, Self-Efficacy, and Problem Severity: Smoking, Diet, and Sun Exposure. 
 Number of Items Response Options Reliability Reference 
Decisional Balance 
Smoking 4 Pros of quitting 
4 Cons of quitting 
1=“Not At All 
Important” to 
5=“Extremely 
Important” 
Pros 
(α=.87) 
Cons 
(α=.90) 
Velicer, DiClemente, 
Prochaska, & 
Brandenburg, 1985 
Diet 3 Pros of high fat 
diet 
3 Cons of high fat 
diet 
1=“Not At All 
Important” to 
5=“Extremely 
Important” 
Pros (α = 
.52) 
 Cons (α = 
.47) 
Greene, Rossi, Rossi, 
Fava et al., 
2001;Greene, Rossi, 
Rossi, Velicer et al., 
1999; Prochaska et al., 
1994; Rossi et al., 
1994b; Rossi, Rossi, & 
Hargreaves, 1997 
Sun Exposure     
Self-Efficacy 
Smoking 9 situational 
temptations 
1=“Not At All 
Tempted” to 
5=“Extremely 
Tempted” 
α =  Velicer, DiClemente, 
Rossi, & Prochaska, 
1990 
Diet 9 situational 
temptations 
1=“Not At All 
Tempted” to 
5=“Extremely 
Tempted” 
α = .71 
 
Greene et al., 
2001;Greene et al., 
1999; Prochaska et al., 
1994; Rossi et al., 
1994b; Rossi, Rossi, & 
Hargreaves, 1997 
Sun Exposure     
Problem Severity 
Smoking 2 items Continuous 
measures: 
number of 
cigarettes time to 
first cigarette 
n/a Fagerstrom, 
Heatherton, & 
Kozlowski, 1990 
Diet Dietary Behavior 
Questionnaire:  
22-items (4 
subscales) 
 
Previous month:  
1=“Never” to 
5=“Almost 
Always” 
α ranges 
from 0.67 
to 0.84  
 
Greene et al., 1996 
Sun Exposure     
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Data Analytic Strategies 
 The primary and secondary aims of this study were achieved by the following 
analyses.  The first set of analyses ran descriptive statistics and bivariate plots to 
determine whether the assumptions of the general linear model (GLM) were met and to 
assess any issues with non-normal data including skewness, kurtosis, and missing data.  
Although logistic regression (LR) does not require GLM assumptions to be met, 
preliminary analyses were critical to ensure LR was an appropriate, and perhaps optimal, 
statistical method for this research.  Were there missing data, multiple imputation (MI) 
would have been utilized as it has been shown to be the most reliable estimation of 
missing data values. 
 H1) Participants in Contemplation (C) or Preparation (PR) at baseline for two 
behaviors will be more likely to move to criteria (Action/Maintenance) on both behaviors 
at final follow-up (i.e., paired action) than participants who are in Precontemplation (PC) 
at baseline for both behaviors. 
 Analysis 1: A series of logistic regression (LR) analyses determined whether 
being in later SOC (i.e., C and PR) at baseline for two behaviors was predictive of more 
stage related paired action as compared to participants in PC at baseline.  Predictors were 
assessed at baseline and 24-month follow-up.  Behavior pairs were examined within the 
treatment and control groups separately, resulting in 6 LR analyses. 
LR was performed to see how well one categorical, independent variable 
predicted membership of a dichotomous dependent variable.  Specifically, LR compared 
the odds of moving to A/M on both behaviors in the behavior pair at 24-month follow-up 
given the participant was either in PC or C/PR for both behaviors at baseline.  Therefore, 
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results show the participants who progressed to criteria as well as the odds ratios of 
progressing to A/M on both behaviors at 24-month follow-up based on whether the 
participant was in PC or C/PR for both behaviors at baseline by treatment condition. 
The independent variables were analyzed by the behavior pairs: 1) sun protection 
and diet, 2) smoking and diet, 3) smoking and sun protection.  Specifically, the dataset 
was categorized to identify participants who were in PC for both behaviors at baseline 
and participants who were in either C or PR for both behaviors at baseline.  Participants 
who were in PC for both behaviors were categorized with a 0 (i.e., ‘being in PC for both 
behaviors’) and participants who were in either C or PR for both behaviors were 
categorized with a 1 (i.e., ‘being in Contemplation or Preparation for both behaviors’).   
The dependent variables were analyzed by the same behavior pairs: 1) sun 
protection and diet, 2) smoking and diet, 3) smoking and sun protection and SOC for both 
behaviors at 24-month follow-up.  Specifically, the dataset was categorized to identify the 
participants who were in A/M for both behaviors in the behavior pair at 24-month follow-
up and the participants who were not in A/M for both behaviors in the behavior pair at 
24-month follow-up.  Participants who did not move to A/M on both behaviors at 24-
month follow-up were categorized with a 0 (i.e., ‘did not change on both behaviors’) and 
participants who did move to A/M on both behaviors at 24-month follow-up were 
categorized with a 1 (i.e., ‘changed on both behaviors’). 
After running each LR, a series of crosstabulations was conducted in order to 
identify the specific number of participants who were in PC for both behaviors at baseline 
and who moved to A/M on both behaviors at 24-month follow-up and the specific 
number of participants who were in C/PR for both behaviors at baseline and moved to 
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A/M on both behaviors at 24-month follow-up by treatment condition.  As such, the 
reported proportions reflect the percentage that number of participants represents relative 
to all the participants who progressed to A/M on both behaviors at follow-up given they 
were either in PC or C/PR at baseline for that treatment condition and not relative to the 
total sample of the study.  In addition, conditional confidence intervals were calculated 
for each proportion of each behavior pair analysis.  Therefore, the reported proportions 
allow for a direct comparison between treatment and control conditions.   
 H2) Participants who make stage progress (i.e., progress at least one stage) on one 
behavior will also make stage progress on a second behavior, with more co-progression 
observed in the treatment than the control group. 
 Analysis 2: A series of LR analyses evaluated the likelihood of whether making 
stage progress on one behavior increases the likelihood of making stage progress on a 
second behavior, and assessed any differences between the treatment and control groups.  
Behavior pairs were examined within the treatment and control groups separately, 
resulting in 6 LR analyses.  
 LR was performed to see how well one categorical, independent variable 
predicted membership of a dichotomous dependent variable.  Specifically, in this 
analysis, LR compared the odds of participants making stage progress on a second 
behavior given stage progress on the first behavior compared to the odds of participants 
making stage progress on the second behavior given no stage progress on the first 
behavior from baseline to 24-month follow-up.  Therefore, the results show the 
participants and odds of making stage progress on both behaviors from baseline to 24-
month follow-up compared to the odds of making stage progress only on the second 
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behavior not having made stage progress on the first behavior from baseline to 24-month 
follow-up.   
The independent and dependent variables were analyzed by the same behavior 
pairs: 1) sun protection and diet, 2) smoking and diet, 3) smoking and sun protection and 
SOC at baseline and at 24-month follow-up by treatment condition.  Specifically, each 
behavior within the pair was dichotomized into participants who did and did not progress 
at least one SOC from baseline to 24-month follow-up on each behavior in the behavior 
pair.  Participants who did not progress at least one SOC were categorized with a 0 (i.e., 
‘stable/regress’) and participants who did progress at least one SOC from baseline to 24-
month follow-up were categorized with a 1 (i.e., ‘stage progress’); with the first behavior 
in the behavior pair as the independent variable and the second behavior in the behavior 
pair as the dependent variable.  All analyses were run separately for the control, 
treatment, and total conditions. 
After running each LR, a series of crosstabulations was conducted in order to 
identify the specific number of participants who made stage progress on the first behavior 
at 24-month follow-up and whether the participant also made stage progress on the 
second behavior at 24-month follow-up by treatment condition.  As such, the reported 
proportions reflect the percentage of participants who made stage progress on the second 
behavior given they made stage progress on the first behavior compared to participants 
who made stage progress on the second behavior not having made stage progress on the 
first behavior in the behavior pair relative to that treatment condition.  Again, conditional 
confidence intervals were calculated for each proportion for each behavior pair by 
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treatment condition.  Therefore, results allow for a direct comparison of the treatment and 
control conditions.  
 H3) Participants who decrease their severity by a defined amount on one behavior 
will also decrease their severity on a second behavior, with more co-progression observed 
in the treatment than the control group. 
 Analysis 3: A series of LR analyses evaluated the likelihood of whether reduction 
in severity on one behavior increased the likelihood of reduction of severity on a second 
behavior, and to assess any differences between the treatment and control groups.  See 
appendix 1. 
LR was performed to see how well one categorical, independent variable 
predicted membership of a dichotomous dependent variable.  Specifically, in this 
analysis, LR compared the odds of participants who had a reduction of severity on the 
second behavior given a reduction of severity on the first behavior compared to 
participants who only had a reduction of severity on the second behavior and did not have 
a reduction of severity on the first behavior from baseline to 24-month follow-up by 
treatment condition.  Therefore, results show the odds of participants who had a reduction 
of severity on both behaviors compared to the odds of reduction of severity only on the 
second behavior from baseline to 24-month by treatment condition.  
Drawing from harm reduction theory and the literature on decisional balance for 
separate behaviors, analyses defined reduction in severity in the following ways.  For 
smoking, reduction in severity was defined as a 30% reduction in smoking from baseline 
to 24-month follow-up.  For diet, reduction in severity was defined as a .3 SD increase on 
the total behavior score at 24-month follow-up.  For sun protection, reduction in severity 
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was defined as a .3 SD increase on the total behavior score at 24-month follow-up.  The 
.3 SD increase on the diet and sun protection behavior measures is based on each measure 
having higher total scores correlated with reduced health risk on that specific behavior. 
The independent and dependent variables were analyzed by the same three 
behavior pairs: 1) sun protection and diet, 2) smoking and diet, 3) smoking and sun 
protection at baseline and at 24-month follow-up.  Specifically, each behavior within the 
pair was dichotomized into participants who did and did not meet reduction in severity 
criteria from baseline to 24-month follow-up.  Participants who did not meet criteria were 
categorized with a 0 (i.e., ‘did not meet reduction in severity criteria’) and participants 
who did meet reduction in severity criteria from baseline to 24-month were categorized 
with a 1 (i.e., ‘did meet reduction in severity criteria’).  All analyses were run separately 
for the control, treatment, and total conditions. 
After running each LR, a series of crosstabulations was conducted to reveal the 
specific number of participants who met criteria for both behaviors in the behavior pair 
by treatment condition compared to the participants who met the reduction on severity 
criteria on the second behavior but did not meet reduction on severity criteria on the first 
behavior.  Thereafter, conditional confidence intervals were then calculated to reveal the 
specific proportion that number of participants represents for each behavior pair by 
treatment condition.  As such, the reported proportions reflect the number of participants 
who met reduction in severity criteria on both behaviors compared to participants who 
only met the reduction of severity criteria on the second behavior but not on the first 
behavior for each behavior pair by treatment condition.  Therefore, results allow for a 
direct comparison between treatment and control conditions.     
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 H4) Participants who increase their Pros and Cons by a defined amount on one 
behavior will do the same for a second behavior, with more co-progression observed in 
the treatment than the control group. 
 Analysis 4: A series of LR analyses evaluated the likelihood of whether increasing 
Pros by one standard deviation and decreasing Cons one half standard deviation on one 
behavior increased the likelihood of doing the same on a second behavior, and assessed 
any differences between the treatment and control groups.  
LR was performed to see how well one categorical, independent variable 
predicted membership of a dichotomous dependent variable.  Specifically, in this 
analysis, LR compared the odds of participants who increased their Pros by one standard 
deviation and reduced their Cons by a half standard deviation on the second behavior 
having met the same criteria on the first behavior compared to participants who only 
increased their Pros by one standard deviation and reduced their Cons by a half standard 
deviation on the second behavior not having met the same criteria on the first behavior 
from baseline to 24-month follow-up by treatment condition.  
Similar to previous analyses, the independent and dependent variables were 
analyzed by behavior pairs: 1) sun protection and diet, 2) smoking and diet, 3) smoking 
and sun protection.  In these analyses, the independent variables (i.e., the first behavior of 
the pair) and the dependent variables (i.e., the second behavior of the pair) were both 
categorized as either increasing Pros one standard deviation and reducing Cons by a half 
standard deviation from baseline to 24-month follow-up on that behavior, either yes or 
no.  Participants who did not meet this criterion were categorized with a 0 (i.e., “did not 
met strong and weak principles”) and participants who met this criterion were categorized 
 29 
 
with a 1 (i.e., “met strong and weak principles”).  Given the stringent criteria, the strong 
and weak principles analyses were not able to be completed as planned because there 
were zero participants who met criteria for behavior pairs across each condition.   
Also, because the original strong and weak principles were based on the 
transitions from participants progressing from PC-A for separate behaviors, and this 
research examined all Stages of Change (SOC) movements including PC-A, C-A, and 
PR-A, a revised approach using a .4 SD Pros increase for each behavior in the behavior 
pair was used to better understand how decisional balance relates to multiple health 
behavior change.  Therefore, in this analysis, LR compared the odds of participants who 
increased their Pros by .4 SD on the second behavior given participants increased their 
Pros .4 SD on the first behavior compared to participants who only increased their Pros .4 
SD on the second behavior, not having increased their Pros by .4 SD on the first 
behavior, from baseline to 24-month follow-up by treatment condition.  
To complete the revised analyses, the same three behavior pairs were examined 
using the same independent and dependent variables: 1) sun protection and diet, 2) 
smoking and diet, 3) smoking and sun protection at baseline and at 24-month follow-up. 
Specifically, the dataset was categorized to identify those participants who made a .4 SD 
increase on Pros on the second behavior given a .4 SD increase on Pros on the first 
behavior, either yes or no (i.e., 1= “met .4 SD Pros increase criteria” and 0= “did not 
meet .4 SD Pros increase criteria”), and participants who only met the .4 SD increase on 
Pros on the second behavior given no .4 SD increase on Pros on the first behavior, either 
yes or no (i.e., 1= “met .4 SD Pros increase criteria” and 0= “did not meet .4 SD Pros 
increase criteria”), from baseline to 24-month follow-up by treatment condition.     
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After running each LR, a series of crosstabulations was conducted to reveal the 
specific number of participants who met the .4 SD increase on Pros criteria for both 
behaviors in the behavior pair compared to the participants who met the .4 SD increase 
on Pros criteria only for the second behavior but not for the first behavior.  As such, the 
reported proportions represents the number of participants who met the .4 SD increase on 
Pros criteria for both behaviors compared to the number of participants who met the .4 
SD increase on Pros criteria only on the second behavior.  Conditional confidence 
intervals were then calculated to reveal the specific proportion that number of participants 
represents for each behavior pair for each treatment condition.  Therefore, results allow 
for a direct comparison between treatment and control conditions.     
 H5) As an exploratory approach, it is expected that participants who move to 
Action/Maintenance on only one behavior will also show smaller signs of success as 
defined by: a) making stage progress on a second behavior, b) decreasing severity on a 
second behavior; and c) increasing their Pros and decreasing their Cons on a second 
behavior.  It is also expected that these changes will be observed in the treatment group 
more than in the control group.  
 Analysis 5: Descriptive statistics and crosstabulations evaluated whether 
participants who moved to criteria (i.e., Action/Maintenance) on only one behavior also 
made smaller changes (described above) on other behaviors.  Upon a thorough review of 
the data, this hypothesis was answered by previous analyses as outlined in the results and 
discussion sections. 
 H6) Paired action and co-progression are not expected to vary by race or gender. 
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Analysis 6: The series of LR analyzed in H2 through H4 were repeated to assess 
any differences in paired action and co-progression rates between race and gender.  The 
same categorization outlined in the previous analyses was repeated with the dataset 
having first been filtered for race (i.e., 0=Whites and 1=Non-Whites) and then re-run 
having been filtered for gender (i.e., 0=females and 1=males).  Therefore, these analyses 
revealed any differences between race and gender on the odds of meeting criteria (i.e., 
defined differently for each hypothesis) on the second behavior having met criteria on the 
first behavior compared to the odds of meeting criteria on the second behavior and not 
having met criteria on the first behavior from baseline to 24-month follow-up for each 
behavior pair by treatment condition.   
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CHAPTER 4 
FINDINGS 
Sample: 
The participants (N=9,461) were predominantly White (93.8%), middle-aged (X= 
43.9 years-old, SD=10.74), female (65.4%), and recruited solely from a Northeastern 
state.  Table 2 provides additional detail on the three referral sources (i.e., parent, patient, 
and worksite) as well as the gender, marital status, and ethnic composition for the control, 
treatment, and total sample.   
Hypotheses: 
H1) Participants in Contemplation (C) or Preparation (PR) at baseline for two 
behaviors will be more likely to move to criteria (Action/Maintenance) on both behaviors 
at final follow-up (i.e., paired action) than participants who are in Precontemplation (PC) 
at baseline for both behaviors. 
Table 3 provides the participants who moved to criteria and the paired action odds 
ratios of progressing to A/M on both behaviors at 24-month follow-up (i.e., the dependent 
variable) given the participant was either in PC or C/PR for both behaviors at baseline 
(i.e., the independent variable).   
Sun Protection and Diet 
Entire Sample: Results were significant, OR=5.40 [2.68, 10.90], p <.001, 
indicating that participants in Contemplation or Preparation (i.e., C/PR) for sun protection 
and diet at baseline were almost five and a half times more likely to progress to 
Action/Maintenance (i.e., A/M) on both behaviors at 24-month follow-up than 
participants who were in Precontemplation (i.e., PC) for both behaviors at baseline.   
 33 
 
Treatment Group: Results were significant, OR=4.53 [1.89, 10.85], p <.001, 
indicating that participants who were in C/PR for sun protection and diet at baseline were 
over four and a half times more likely to move to A/M on sun protection and diet than 
participants who were in PC for both behaviors at baseline.   
Control Group: Results were significant, OR=6.97 [2.11, 23.04], p <.001, 
indicating that participants who were in C/PR for both behaviors were almost seven times 
more likely to move to A/M on both sun protection and diet than participants who were in 
PC for both behaviors at baseline.      
Smoking and Diet 
Entire Sample: Results were not significant, OR=2.22, [0.79, 6.27], p <.132, 
indicating that although participants in C/PR for both smoking and diet at baseline were 
more than two times more likely to progress to A/M on smoking and diet at 24-month 
follow-up than participants who were in PC for both behaviors at baseline, the odds ratio 
between the groups was not reliably different.   
Treatment Group. Results were not significant, OR=2.22 [0.45, 10.98], p <.330, 
indicating that although participants who were in C/PR for smoking and diet at baseline 
were more than two times more likely to progress to A/M on both behaviors at 24-month 
follow-up than participants who were in PC for both behaviors at baseline, the difference 
between the groups was not significantly different.   
Control Group. Results were not significant, OR=2.14 [0.54, 8.44], p <.278, 
indicating that although participants who were in C/PR for both behaviors were more 
than two times more likely to progress to A/M on smoking and diet at 24-month follow-
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up than participants who were in PC for both behaviors at baseline, the odds ratio 
between participants who were in C/PR compared to PC was not significant.   
Smoking and Sun Protection 
Entire Sample: Results were significant, OR=4.38 [1.00, 19.03], p <.049, 
indicating that participants who were in C/PR for smoking and sun protection at baseline 
were more than four times more likely to progress to A/M on both behaviors at 24-month 
follow-up than participants who were in PC for both behaviors at baseline.   
Treatment Group. Odds ratios were not able to be calculated between the groups 
because zero participants who were in PC for both behaviors at baseline progressed to 
A/M on both behaviors at 24-month follow-up.  Therefore, although 14 participants who 
were in C/PR for both behaviors at baseline did progress to A/M on both behaviors at 24-
month follow-up, odds ratios could not be calculated because zero participants met 
criteria in the comparison group.  
Control Group. Results were not significant, OR=1.20 [0.23, 6.30], p <.831, 
indicating that although participants who were in C/PR for smoking and sun protection 
were more likely to progress to A/M on both behaviors at 24-month follow-up, the 
difference between the comparison groups was not significant.   
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Table 2. Demographics and descriptive statistics for control, treatment, and total sample, baseline-24 months#. 
    Control Treatment  Total 
   (N=4800) (N=4661)  (N=9461) 
    N %  N %  N % 
Study Parent 1238 25.8%  1197 25.7%  2435 25.7% 
  
Patient 2620 54.6%  2550 54.7%  5170 54.6% 
  
Worksite 942 19.6%  914 19.6%  1856 19.6% 
  
 
        
Gender Male 1596 34.6%  1545 34.6%  3141 34.6% 
  
Female 3017 65.4%  2921 65.4%  5938 65.4% 
  
 
        
Marital Status Married 3265 70.9%  3176 71.3%  6441 71.1% 
  
Not Married, living w/Partner 163 3.5%  157 3.5%  320 3.5% 
  
Not Married 460 10.0%  462 10.4%  922 10.2% 
  
Separated 89 1.9%  90 2.0%  179 2.0% 
  
Divorced 480 10.4%  452 10.1%  932 10.3% 
  
Widowed 149 3.2%  119 2.7%  268 3.0% 
  
 
        
Ethnicity American Indian, Alaskan 21 0.5%  20 0.4%  41 0.5% 
  
Asian, Pacific Islander 40 0.9%  34 0.8%  74 0.8% 
  
Black, Non-Hispanic 74 1.6%  82 1.8%  156 1.7% 
  
Hispanic 46 1.0%  45 1.0%  91 1.0% 
  
White 4319 93.7%  4184 93.8%  8503 93.7% 
  
Other/Combination 109 2.4%  96 2.2%  205 2.3% 
  
 
        
    
Mean SD N Mean SD  Mean SD 
           
  Age 44.07 10.7 4589 43.74 10.7  43.90 10.7 
          
# Recruited in 1999 in the United States. 
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Table 3. Comparison of paired action rates among participants who were either in Precontemplation (PC)  
or in Contemplation/Preparation (C/PR) for both behaviors at baseline and were in 
Action/Maintenance (A/M) for both behaviors at 24-month follow-up. 
 
 
  
Control 
Proportion (n/total N) 
Confidence Interval 
 
 
Treatment 
Proportion (n/total N) 
Confidence Interval 
 
 
Total 
Proportion (n/total N) 
Confidence Interval 
Sun Protection & Diet 
 
   
Paired Action: Participants who 
progressed to A/M on sun protection 
and diet given PC at baseline  
.01 (3/401) 
[.00, .02] 
.02 (6/261) 
[.00, .04] 
.01 (9/662) 
[.00, .02] 
Paired Action: Participants who 
progressed to A/M on sun protection 
and diet given C/PR at baseline 
  .05 (29/581) 
[.03, .07] 
.10 (40/415) 
[.07, .13] 
.07 (69/996) 
[.05, .09] 
 
Paired action odds ratioa 
 
6.97*** (2.11, 23.04) 
 
4.53*** (1.89, 10.85) 
 
5.40*** (2.68, 10.90) 
Smoking & Diet 
 
   
Paired Action: Participants who 
progressed to A/M on smoking and 
diet given PC at baseline  
.02 (3/134) 
 [.00, .04] 
.03 (2/71)  
[.00, .07] 
.02 (5/205)  
[.00, .04] 
Paired Action: Participants who 
progressed to A/M on smoking and 
diet given C/PR at baseline 
.05 (7/150) 
 [.02, .08] 
.06 (7/116)  
[.02, .10] 
.07 (14/266)  
[.04, .10] 
 
Paired action odds ratioa 
 
2.14 (0.54, 8.44) 
 
2.22 (0.45, 10.98) 
 
2.22 (0.79, 6.27) 
Smoking & Sun Protection 
 
   
Paired Action: Participants who 
progressed to A/M on smoking and 
sun protection given PC at baseline  
.02 (2/95) 
 [.00, .05] 
.00 (0/60) 
 [.00, .00] 
.01 (2/155)  
[.00, .02] 
Paired Action: Participants who 
progressed to A/M on smoking and 
sun protection given C/PR at baseline 
.03 (5/199)  
[.00, .05] 
.09 (14/152)  
[.05, .14] 
.05 (19/351)  
[.03, .08] 
 
Paired action odds ratioa 
 
1.20 (0.23, 6.30) 
 
0.00 (0.00, 0.00) 
 
4.38** (1.00, 19.03) 
** p< .05. *** p< .001; 
a
 Percentages in control and treatment conditions reflect proportion within that condition, not the total; 
# Recruited in 1999 in the United States. 
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H2) Participants who make stage progress (i.e., progress at least one stage) on one 
behavior will also make stage progress on a second behavior, with more co-progression 
observed in the treatment than the control group. 
Table 4 provides the participants who progressed to criteria and the co-
progression odds ratios of making stage progress on a second behavior given stage 
progress on the first behavior compared to the odds of participants who made stage 
progress on the second behavior not having made stage progress on the first behavior 
from baseline to 24-month follow-up for each behavior pair and treatment condition. 
Sun Protection and Diet 
Entire Sample: Results were significant, OR= 1.46 [1.25, 1.70], p < .000, 
indicating that participants who made stage progress on diet given stage progress on sun 
protection were almost one and a half times more likely to make stage progress on diet 
compared to participants who only made stage progress on diet.   
Treatment Group: Results were significant, OR= 1.85 [1.48, 2.32], p < .000, 
indicating that participants who made stage progress on diet given stage progress on sun 
protection were almost twice as likely to make stage progress on diet compared to 
participants who only made stage progress on diet.   
Control Group: Results were not significant, OR= 1.10 [0.88, 1.37], p < .414, 
indicating that although participants who made stage progress on diet given stage 
progress on sun protection were slightly more likely to make stage progress on diet 
compared to participants who only made stage progress on diet, the difference between 
the comparison groups was not significant.     
Smoking and Diet 
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Entire Sample: Results were significant, OR= 1.40 [1.05, 1.86], p < .021, 
indicating that participants who made stage progress on diet given stage progress on 
smoking were almost one and a half times more likely to make stage progress on diet 
compared to participants who only made stage progress on diet.   
Treatment Group: Results were not significant, OR= 1.17 [0.76, 1.80], p < .484, 
indicating that although participants who made stage progress on diet given stage 
progress were slightly more likely to make stage progress on diet compared to 
participants who only made stage progress on diet, the difference between the groups was 
not reliable.   
Control Group: Results were significant, OR= 1.56 [1.07, 2.28], p < .021, 
indicating that participants who made stage progress on diet given stage progress on 
smoking were more than one and a half times more likely to make stage progress on diet 
compared to participants who only made stage progress on diet.     
Smoking and Sun Protection 
Entire Sample: Results were not significant, OR= 1.16 [0.87, 1.55], p < .305, 
indicating that although participants who made stage progress on sun protection given 
stage progress on smoking were slightly more likely to make stage progress on sun 
protection compared to participants who only made stage progress on sun protection, the 
difference between the comparison groups was not significant.   
Treatment Group: Results were not significant, OR= 1.22 [0.81, 1.85], p < .358, 
indicating that although participants who made stage progress on sun protection given 
stage progress on smoking were almost one and a quarter times more likely to make 
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progress on sun protection compared to participants who only made stage progress on sun 
protection, the difference between the comparison groups was not significant.   
Control Group: Results were not significant, OR= 1.03 [0.70, 1.55], p < .907, 
indicating that although participants who made stage progress on sun protection given 
stage progress on smoking were slightly more likely to make stage progress on sun 
protection compared to participants who only made stage progress on sun protection, the 
difference between the comparison groups was not significant.   
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Table 4. Stage progress co-progression rates from baseline to 24-month follow-up by treatment condition#;  
Percentages in control and treatment conditions reflect proportion within that condition, not total. 
 
 
 
Control 
Proportion (n/total N) 
Confidence Interval 
 
 
Treatment 
Proportion (n/total N) 
Confidence Interval 
 
 
Total 
Proportion (n/total N) 
Confidence Interval 
Sun Protection & Diet 
 
   
Participants who made stage progress 
on diet given stage progress on sun 
protection 
.34 (167/498) 
[.29, .38] 
.48 (256/536) 
[.33, .57] 
.41 (423/1034) 
[.38, .44] 
Participants who made stage progress 
on diet given no stage progress on sun 
protection 
.32 (399/1266) 
[.29, .34] 
 
.33 (256/774) 
[.30, .36] 
.32 (655/2040) 
[.30, .34] 
 
Co-progression odds ratioa 
 
1.10 (0.88, 1.37) 
 
1.85***(1.48, 2.32) 
 
1.46***(1.25, 1.70) 
Smoking & Diet 
 
   
Participants who made stage progress 
on diet given stage progress on 
smoking 
.37 (69/188) 
[.30, .44] 
 
.39 (57/148) 
[.31, .46] 
.38 (126/336) 
[.32, .43] 
Participants who made stage progress 
on diet given no stage progress on 
smoking 
.27 (95/351) 
[.22, .32] 
 
.35 (74/212) 
[.28, .41] 
.30 (169/563) 
[.26, .34] 
 
Co-progression odds ratioa 
 
1.56**(1.07, 2.28) 
 
1.17 (0.76, 1.80) 
 
1.40** (1.05, 1.86) 
Smoking & Sun Protection 
 
   
Participants who made stage progress 
on sun protection given stage progress 
on smoking 
.27 (47/175) 
[.20, .33] 
.39 (65/167) 
[.32, .46] 
.33 (112/342) 
[.23, .43] 
Participants who made stage progress 
on sun protection given no stage 
progress on smoking 
.26 (91/345) 
[.22, .31] 
.34 (76/221) 
[.28, .41] 
.30 (167/586) 
[.26, .34] 
 
Co-progression odds ratioa 
 
1.03 (0.70, 1.55) 
 
1.22 (0.81, 1.85) 
 
1.16 (0.87, 1.55) 
** p< .05. *** p< .001; 
a
 Co-progression rates of stage progress on second behavior given stage progress on the first behavior; 
# Recruited in 1999 in the United States. 
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H3) Participants who decrease their severity by a defined amount on one behavior 
will also decrease their severity on a second behavior, with more co-progression observed 
in the treatment than the control group. 
Table 5 provides the participants who progressed to criteria and the co-
progression odds ratios of reduction on severity on a second behavior given reduction on 
severity on the first behavior compared to the odds of participants who had a reduction on 
severity on the second behavior not having reduced severity on the first behavior from 
baseline to 24-month follow-up for each behavior pair by treatment condition.  
Specifically, reduction on severity was defined as a 30% reduction in the number of 
cigarettes smoked from baseline to 24-month follow-up and at least a .3 SD increase on 
the diet behavior total score for diet and a .3 SD increase on the sun exposure behavior 
total score for unprotected sun exposure, both from baseline to 24-month follow-up.   
Sun Protection and Diet 
Entire Sample: Results were significant, OR= 1.26 [1.09, 1.46], p < .002, 
indicating that participants who had a reduction on severity on diet given a reduction on 
severity on sun protection were more than one and a quarter times more likely to reduce 
severity on diet compared to participants who only reduced severity on diet alone.   
Treatment Group: Results were significant, OR= 1.34 [1.08, 1.67], p < .008, 
indicating that participants who reduced severity on diet given reduced severity on sun 
protection were more than one and a third times more likely to reduce severity on diet 
compared to participants who only reduced severity on diet alone. 
Control Group: Results were not significant, OR= 1.11 [0.92, 1.35], p < .280, 
indicating that although participants were slightly more likely to reduce severity on diet 
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given reduced severity on sun protection compared to participants who reduced severity 
on diet alone, the difference between the comparison groups was not reliable.    
Smoking and Diet 
Entire Sample: Results were significant, OR= 1.40 [1.01, 1.77], p < .039, 
indicating that participants who reduced severity on diet given reduced severity on 
smoking were more than one and a third times more likely to reduce severity on diet 
compared to participants who only reduced severity on diet alone.   
Treatment Group: Results were not significant, OR= 0.94 [0.62, 1.44], p < .787, 
indicating that although participants had a slightly lower likelihood of a reduction on 
severity diet given a reduction of severity on smoking compared to participants who had 
a reduction on diet alone, the difference between the comparison groups was not reliable.     
Control Group: Results were significant, OR= 1.69 [1.17, 2.45], p < .005, 
indicating that participants who reduced severity on diet given reduced severity on 
smoking were more than one and a half times more likely to reduce severity on diet 
compared to participants who only reduced severity on diet alone.   
Smoking and Sun Protection 
Entire Sample: Results were not significant, OR= 1.16 [0.88, 1.52], p < .288, 
indicating that although participants who reduced severity on sun protection given 
reduced severity on smoking were slightly more likely to reduce severity on sun 
protection compared to participants who only reduced severity on sun protection alone, 
the difference between the groups was not reliable.   
Treatment Group: Results were not significant, OR= 1.35 [0.90, 2.05], p < .152, 
indicating that although participants who reduced severity on sun protection given 
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reduced severity on smoking were more likely to reduce severity on sun protection 
compared to participants who only reduced severity on sun protection alone, the 
difference between this group was not reliably different. 
Control Group: Results were not significant, OR= 1.00 [0.70, 1.44], p < .987, 
indicating that although participants who reduced severity on sun protection given 
reduced severity on smoking were just as likely to reduce harm on sun protection as 
participants who only reduced harm on sun protection alone, the difference between the 
comparison groups was not reliable.  
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Table 5.Reduction on severity co-progression rates baseline to 24-month follow-up by treatment condition#; 
 30% reduction in smoking and a .3 SD reduction in severity on diet and sun total behavior scores; 
 Percentages in control and treatment conditions reflect proportion within that condition, not total. 
 
 
 
Control 
Proportion (n/total N) 
Confidence Interval 
 
Treatment 
Proportion (n/total N) 
Confidence Interval 
 
Total 
Proportion (n/total N) 
Confidence Interval 
Sun Protection & Diet  
 
  
Participants who reduced severity on 
diet given reduced severity on sun 
protection 
.38 (307/814) 
[.35,.41] 
  
.52 (379/733) 
[.48,.56] 
.44 (686/1547) 
[.42,.46] 
Participants who reduced severity on 
diet given no reduced severity on sun 
protection 
.35 (339/962) 
[.32,.38] 
 
.44 (262/590) 
[.40,.48] 
.39 (601/1552) 
[.37,.41] 
 
Co-progression odds ratioa  
 
1.11 (0.92, 1.35) 
 
1.34**  (1.08, 1.67) 
 
1.26**  (1.09, 1.46) 
Smoking & Diet 
 
   
Participants who reduced severity on 
diet given reduced severity on 
smoking 
.43 (75/176) 
[.36,.50] 
 
.44 (60/138) 
[.36,.52] 
.43 (135/314) 
[.38,.48] 
Participants who reduced severity on 
diet given no reduced severity on 
smoking 
.31 (116/380) 
[.26,.36] 
 
.45 (106/236) 
[.39,.51] 
.36 (222/616) 
[.32,.40] 
 
Co-progression odds ratioa 
 
1.69**  (1.17, 2.45) 
 
0.94 (0.62, 1.44) 
 
1.40**  (1.01, 1.77) 
Smoking & Sun Protection 
 
   
Participants who reduced severity on 
sun protection given reduced severity 
on smoking 
.47 (80/170) 
[.39,.55] 
.60 (84/141) 
[.52,.68] 
.53 (164/311) 
[.47,.59] 
Participants who reduced severity on 
sun protection given no reduced 
severity on smoking 
.47 (179/381) 
[.42,.52] 
.52 (136/261) 
[.46,.58] 
.49 (315/642) 
[.45,.53] 
 
Co-progression odds ratioa 
 
1.00 (0.70, 1.44) 
 
1.35 (0.90, 2.05) 
 
1.16 (0.88, 1.52) 
** p< .05. *** p< .001; 
a
 Odds of stage progress on second behavior given stage progress on the first behavior; 
# Recruited in 1999 in the United States. 
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H4) Participants who increase their Pros and Cons by a defined amount on one 
behavior will do the same for a second behavior, with more co-progression observed in 
the treatment than the control group. 
 Table 6 provides the participants and co-progression odds ratios for participants 
who made a .4 SD increase in Pros on the second behavior given a .4 SD increase in Pros 
on the first behavior compared to participants who only made a .4 SD increase on the 
second behavior in the behavior pair from baseline to 24-month follow-up by treatment 
condition.   
Sun Protection and Diet 
Entire Sample: Results were significant, OR= 1.38 [1.14, 1.67], p < .001, 
indicating that participants who increased their Pros by .4 SD on diet given a .4 SD 
increase of their Pros on sun protection were more than one and a third times more likely 
to increase their Pros .4 SD on diet compared to participants who only increased their 
Pros .4 SD on diet alone.   
Treatment Group: Results were not significant, OR= 1.06 [0.79, 1.43], p < .693, 
indicating that although participants who increased their Pros on diet by .4 SD given they 
also increased their Pros .4 SD on sun protection were slightly more likely to increase 
their Pros .4 SD on diet compared to participants who only increased their Pros by .4 SD 
on diet, the difference between the comparison groups was not reliable.    
Control Group: Results were significant, OR= 1.71 [1.33, 2.19], p < .000, 
indicating that participants who increased their Pros .4 SD on diet given they increased 
their Pros .4 SD on sun protection were almost two times as likely to increase their Pros 
.4 SD on diet compared to participants who increased their Pros .4 SD on diet alone.   
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Smoking and Diet 
Entire Sample: Results were not significant, OR= 1.38 [0.97, 1.97], p < .072, 
indicating that although participants who increased their Pros .4 SD from baseline to 24-
month follow-up on diet given they increased their Pros .4 SD on smoking were almost 
one and a half times more likely to increase their Pros by .4 SD on diet compared to 
participants who increased their Pros on diet alone, the difference between the 
comparison groups was not reliable.   
Treatment Group: Results were significant, OR=1. 75 [0.99, 3.09], p < .052, 
indicating that smokers who increased their Pros .4 SD on diet given a .4 SD increase on 
Pros on smoking had a one and three quarter increased likelihood of increasing their Pros 
.4 SD on diet compared to smokers who only increased their Pros by .4 SD on diet alone.   
Control Group: Results were not significant, OR= 1.19, [0.76, 1.87], p < .448, 
indicating that although participants who increased their Pros .4 SD on diet given a .4 SD 
increased Pros on smoking were almost one and a quarter times more likely to increase 
their Pros on diet by .4 SD compared to smokers who only increased their Pros by .4 SD 
on diet, the difference between the comparison groups was not reliable.   
Smoking and Sun Protection 
Entire Sample: Results were significant, OR= 1.48 [1.07, 2.05], p < .019, 
indicating that participants who increased their Pros .4 SD on sun protection given a .4 
SD increased Pros on smoking were almost one and a half times more likely to increase 
their Pros .4 SD on sun protection compared to smokers who only increased their Pros .4 
SD on sun protection alone, the difference between the comparison groups was not 
reliable.    
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Treatment Group: Results were not significant, OR= 1.07 [0.64, 1.78], p < .799, 
indicating that although participants who increased their Pros .4 SD on sun protection 
given a .4 SD increased Pros on smoking were slightly more likely to increase their Pros 
.4 SD on sun protection compared to participants who increased their Pros by .4 SD on 
sun protection alone, the difference between the comparison groups was not reliable.   
  Control Group: Results were significant, OR= 1.87 [1.22, 2.87], p < .004, 
indicating that smokers who increased their Pros .4 SD on sun protection given a .4 SD 
increased Pros on smoking were almost two times more likely to increase their Pros by .4 
SD on sun protection compared to smokers who increased their Pros by .4 SD on sun 
protection alone.        
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Table 6. .4 SD Pros increase on both behaviors from baseline to 24-mo. follow-up by treatment condition#;   
Percentages in control and treatment conditions reflect proportion within that condition, not total; 
 
 
Control 
Proportion (n/total N) 
Confidence Interval 
 
Treatment 
Proportion (n/total N) 
Confidence Interval 
 
Total 
Proportion (n/total N) 
Confidence Interval 
Sun Protection & Diet 
 
   
Participants with .4 SD Pros increase 
on diet given a .4 SD Pros increase 
on sun protection 
.29 (124/425) 
[.25,.33] 
 
.21 (79/384) 
[.17,.25] 
.25 (203/809) 
[.22,.28] 
Participants with .4 SD Pros increase 
on diet given no .4 SD Pros increase 
on sun protection 
.19 (249/1281) 
[.17,.21] 
 
.20 (170/867) 
[.17,.23] 
.20 (419/2148) 
[.18,.22] 
 
Co-progression odds ratioa 
 
1.71*** (1.33, 2.19) 
 
1.06 (0.79, 1.43) 
 
1.38*** (1.14, 1.67) 
Smoking & Diet 
 
   
Participants with .4 SD Pros increase 
on diet given a .4 SD Pros increase 
on smoking 
.24 (35/145) 
[.20,.28] 
 
.28 (23/82) 
[.18,.38] 
.26 (58/227) 
[.20,.32] 
Participants with .4 SD Pros increase 
on diet given no .4 SD Pros increase 
on smoking 
.21 (82/389) 
[.17,.25] 
 
.18 (51/280) 
[.13,.23] 
.20 (133/669) 
[.17,.23] 
 
Co-progression odds ratioa 
 
1.19 (0.76, 1.87) 
 
1.75** (0.99, 3.09) 
 
1.38 (0.97, 1.97) 
Smoking & Sun Protection 
 
   
Participants with .4 SD Pros increase 
on sun protection given a .4 SD Pros 
increase on smoking 
.35 (46/130) 
[.27,.43] 
.28 (27/96) 
[.19,.37] 
.32 (73/226) 
[.26,.38] 
Participants with .4 SD Pros increase 
on sun protection given no .4 SD 
Pros increase on smoking 
.23 (95/420) 
[.19,.27] 
.25 (82/306) 
[.212,.32] 
.24 (177/726) 
[.21,.27] 
 
Co-progression odds ratioa 
 
1.87**  (1.22, 2.87) 
 
1.07 (0.64, 1.78) 
 
1.48**  (1.07, 2.05) 
** p< .05. *** p< .001; 
a
 Odds of increasing Pros by .4 SD on second behavior given increased Pros by .4 SD on the first behavior; 
# Recruited in 1999 in the United States. 
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H5) As an exploratory approach, it is expected that participants who move to 
Action/Maintenance on only one behavior will also show smaller signs of success as 
defined by: a) making stage progress on a second behavior, b) decreasing severity on a 
second behavior; and c) increasing their Pros and decreasing their Cons on a second 
behavior.  It is also expected that these changes will be observed in the treatment group 
more than in the control group.  
For part “a” of hypothesis 5, a series of crosstabulations explored whether 
participants who progressed to A/M on the first behavior of the behavior pair at 24-month 
follow-up made stage progress on the second behavior at 24-month follow-up.  After 
completing the crosstabulations, it was clear that this part of hypothesis 5 was answered 
in the first and second set of logistic regressions.  Specifically, the first set of logistic 
regression analyses calculated the odds ratios for participants in earlier (i.e., PC) versus 
later (i.e., C/PR) stages of change (SOC) at baseline and whether they moved to A/M on 
both behaviors at 24-month follow-up.  The second set of logistic regression analyses 
calculated the odds ratios of participants who made stage progress on either or both 
behaviors in the behavior pair from baseline to 24-month follow-up, regardless of 
baseline stage of change.  That is, unlike the first set of logistic regressions, the second 
set of analyses allowed participants to be in either PC, C, PR, or A for either or both of 
the behaviors in the behavior pair and to progress one stage by 24-month follow-up.  
After identifying those participants, analyses calculated the odds ratios between the 
participants who made stage progress on the second behavior given stage progress on the 
first behavior compared to the participants who only made stage progress on the second 
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behavior from baseline to 24-month follow-up.  Given the thorough and more stringent 
criteria for these analyses, part “a” of this hypothesis was already answered. 
For part “b” of hypothesis 5, a series of crosstabulations explored whether 
participants who progressed to A/M on the first behavior of the behavior pair at 24-month 
follow-up reduced severity on the second behavior at 24-month follow-up.  Similar to the 
initial set of planned analyses for hypothesis 3, there was insufficient sample size to 
complete analyses as initially planned.  Similar to part “a” of this hypothesis, this part of 
hypothesis 5 was already answered by the logistic regressions performed for hypothesis 
3.  Specifically, the reduction in severity analyses (i.e., 30% reduction in smoking and a 
.3 SD reduction in harm on diet and unprotected sun exposure) as presented in hypothesis 
3 answered this part of the hypothesis.    
For part “c” of hypothesis 5, a series of crosstabulations explored whether 
participants who progressed to A/M on the first behavior of the behavior pair at 24-month 
follow-up increased their Pros one standard deviation and reduced their Cons by a half 
standard deviation on the second behavior at 24-month follow-up.  Similar to the original 
analyses for hypothesis 4, there was an insufficient sample size in order to conduct these 
analyses as there was zero and at most three participants who met the strong and weak 
principle criteria on the first behavior with even fewer participants who met the criteria 
for the second behavior.  Therefore, the revised analyses (i.e., .4 SD Pros increase) for 
each behavior in the same three behavior pairs as presented in hypothesis 4 will be relied 
upon to answer this part of hypothesis 5.   
For the last part of hypothesis 5, expecting greater co-progression rates in 
treatment versus control conditions, this will be evaluated in the discussion section as a 
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general conclusion based on the overall results of this research.  That is, the discussion 
will consist of empirically supported conclusions based on the general and specific 
findings of this research. 
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H6) Paired action and co-progression are not expected to vary by race or gender. 
Stage progress (i.e., H2) by race and gender 
Table 7 presents the participants who progressed to criteria and the co-progression 
odds ratios of making stage progress on the second behavior given stage progress on the 
first behavior compared to the participants who made stage progress on the second 
behavior not having made stage progress on the first behavior from baseline to 24-month 
follow-up for Whites and Non-Whites.   
Sun Protection and Diet 
Results were significant for Whites, OR= 1.49 [1.27, 1.74], p < .001, indicating 
that Whites were almost one and half times more likely to make stage progress on diet 
given stage progress on sun protection compared to Whites who only made stage 
progress on diet.  However, results were not significant for Non-Whites, OR= 1.24 [0.59, 
2.60], p < .578, indicating that although Non-Whites were slightly more likely to make 
stage progress on diet given stage progress on sun protection compared to Non-Whites 
who only made stage progress on diet alone, the difference between the Non-White 
comparison groups was not reliable. 
Smoking and Diet 
Results were significant for Whites, OR= 1.41 [1.05, 1.89], p < .021, indicating 
that Whites were almost one and a half times more likely to make stage progress on diet 
given stage progress on smoking compared to Whites who only made stage progress on 
diet.  However, results were not significant for Non-Whites, OR= 1.11 [0.29, 4.31], p < 
.879, indicating that although Non-Whites had a slightly higher likelihood of making 
stage progress on diet given stage progress on smoking compared to Non-Whites who 
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only made stage progress on diet, the difference between the Non-White comparison 
groups was not reliable.    
Smoking and Sun Protection  
Results were not significant for Whites, OR= 1.16 [0.86, 1.56], p < .334, or Non-
Whites, OR= 1.26, [0.30, 5.30], p < .755, indicating that although both races were 
slightly more likely to make stage progress on sun protection given stage progress on 
smoking compared to their cohort who only made stage progress on sun protection, the 
difference between the comparison groups within each race was not reliable. 
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Table 7. Stage progress on second behavior given stage progress on the first behavior by race; 
Co-progression odds ratios from baseline to 24 months#. 
 
 
Whites 
Proportion (n/total N) 
Confidence Interval 
Non-Whites 
Proportion (n/total N) 
Confidence Interval 
Sun Protection & Diet 
 
  
Participants who made stage progress on diet 
given stage progress on sun protection 
.41 (405/980) 
[.38, .44] 
 
.35 (18/52) 
[.22, .48] 
Participants who made stage progress on diet 
given no stage progress on sun protection 
.32 (628/1953) 
[.29, .34] 
 
.30 (24/80) 
[.20, .40] 
 
Co-progression odds ratioa  
 
1.49*** (1.27, 1.74) 
 
1.24 (0.59, 2.60) 
Smoking & Diet 
 
  
Participants who made stage progress on diet 
given stage progress on smoking 
.38 (120/320) 
[.33, .43] 
 
.36 (5/14) 
[.11, .61] 
Participants who made stage progress on diet 
given no stage progress on smoking 
.30 (159/533) 
[.26, .34] 
 
.33 (9/27) 
[.15, .51] 
 
Co-progression odds ratioa 
 
1.41** (1.05, 1.89) 
 
1.11 (0.29, 4.31) 
Smoking & Sun Protection 
 
  
Participants who made stage progress on sun 
protection given stage progress on smoking 
.33 (107/329) 
[.28, .38] 
 
.36 (4/11) 
[.08, .64] 
Participants who made stage progress on sun 
protection given no stage progress on smoking 
.29 (157/534) 
[.25, .33] 
 
.31 (10/32) 
[.15, .47] 
 
Co-progression odds ratioa 
 
1.16 (0.86, 1.56) 
 
1.26 (0.30, 5.30) 
** p< .05. *** p< .001. 
a
 Odds of stage progress on the second behavior given stage progress on the first behavior; 
# Recruited in 1999 in the United States. 
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Table 8 presents the participants who progressed to criteria and the co-progression 
odds ratios of making stage progress on the second behavior given stage progress on the 
first behavior compared to making stage progress on the second behavior and not having 
made stage progress on the first behavior from baseline to 24-month follow-up for males 
and females. 
Sun Protection and Diet 
Results were significant for males, OR= 1.72 [1.35, 2.20], p <.001, and females, 
OR= 1.30 [1.06, 1.59], p < .01 indicating that both sexes were more likely to make stage 
progress on diet given stage progress on sun protection compared to their cohort on 
making stage progress on diet alone; with males almost one and three quarters more 
likely and females almost one and a half times more likely to make stage progress on diet 
and sun protection compared to diet alone.     
Smoking and Diet 
Results were not significant for males, OR= 1.62 [.98, 2.69], p < .062, or females, 
OR= 1.31, [0.92, 1.85], p < .132, indicating that although each sex was more likely to 
make stage progress on diet given stage progress on smoking compared to making stage 
progress on diet alone, the differences within the respective cohorts was not reliable. 
Smoking and Sun Protection 
Results were not significant for males, OR= 1.48 [0.88, 2.45], p < .133, or 
females, OR= 1.05 [0.74, 1.51], p < .774, indicating that although both sexes had 
increased likelihood of making stage progress on sun protection given stage progress on 
smoking compared to their cohort who only made stage progress on sun protection alone, 
the differences within the comparison groups was not reliable. 
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Table 8. Stage progress on second behavior given stage progress on the first behavior by gender; 
Co-progression odds ratios from baseline to 24 months#. 
 
 
Males 
Proportion (n/total N) 
Confidence Interval 
Females 
Proportion (n/total N) 
Confidence Interval 
Sun Protection & Diet 
 
  
Participants who made stage progress on diet 
given stage progress on sun protection 
.40 (162/410) 
[.35, .45] 
 
.42 (261/623) 
[.38, .46] 
Participants who made stage progress on diet 
given no stage progress on sun protection 
.28 (248/902) 
[.25, .31] 
 
.36 (404/1132) 
[.33, .39] 
 
Co-progression odds ratioa 
 
1.72***(1.35, 2.20) 
 
1.30**  (1.06, 1.59) 
Smoking & Diet 
 
  
Participants who made stage progress on diet 
given stage progress on smoking 
.35 (40/114) 
[.26, .44] 
 
.39 (85/220) 
[.33, .45] 
Participants who made stage progress on diet 
given no stage progress on smoking 
.25 (47/188) 
[.19, .31] 
 
.33 (121/372) 
[.28, .38] 
 
Co-progression odds ratioa 
 
1.62 (0.98, 2.69) 
 
1.31 (0.92, 1.85) 
Smoking & Sun Protection 
 
  
Participants who made stage progress on sun 
protection given stage progress on smoking 
.30 (38/129) 
[.22, .38] 
 
.35 (73/211) 
[.30, .38] 
Participants who made stage progress on sun 
protection given no stage progress on smoking 
.22 (43/195) 
[.16, .28] 
 
.33 (124/371) 
[.29, .41] 
 
Co-progression odds ratioa 
 
1.48 (0.88, 2.45) 
 
1.05 (0.74, 1.51) 
 ** p< .05. *** p< .001. 
a
 Odds of stage progress on the second behavior given stage progress on the first behavior; 
# Recruited in 1999 in the United States. 
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Reduction on severity (i.e., H3) by race and gender 
Table 9 presents the participants who progressed to criteria and the co-progression 
odds ratios for reduction on severity for each behavior pair from baseline to 24-month 
follow-up by race.  Specifically, Table 9 presents the participants and odds of reduction 
on severity on the second behavior given reduction of severity on the first behavior 
compared to the reduction of severity on the second behavior and no reduction on 
severity on the first behavior from baseline to 24-month follow-up for Whites and Non-
Whites.   
Sun Protection and Diet 
Results were significant for Whites, OR= 1.28 [1.10, 1.48], p < .001, indicating 
that Whites were more than one and a quarter times more likely to reduce severity on diet 
given reduced severity on sun protection compared to Whites who only reduced severity 
on diet alone.  However, results were not significant for Non-Whites, OR= 1.02 [0.50, 
2.05], p < .968, indicating that although Non-Whites were slightly more likely to reduce 
severity on diet given reduced severity on sun protection compared to Non-Whites who 
reduced severity on diet alone, the difference within the Non-White comparison groups 
was not reliable. 
Smoking and Diet 
Results were significant for Whites, OR= 1.35 [1.02, 1.80], p < .037, indicating 
that Whites were more than one and a third times more likely to reduce severity on diet 
given reduced severity on smoking compared to Whites who reduced severity on diet 
alone.  In contrast, results were not significant for Non-Whites, OR= 1.59 [0.40, 6.38], p 
< .515, indicating that although Non-Whites who reduced severity on diet given reduced 
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severity on smoking were more than one and a half times more likely to reduce severity 
on diet compared to Non-Whites who reduced severity on diet alone, the difference 
within the comparison group was not reliable.   
Smoking and Sun protection 
Results were not significant for Whites, OR= 1.16 [0.88, 1.53], p < .287, or Non-
Whites, OR= 1.07 [0.28, 4.12], p < .920, indicating that although both groups were 
slightly more likely to reduce severity on sun protection given reduced severity on 
smoking compared to reduced severity on sun protection alone, the differences within 
each comparison group was not reliable.  
  
 59 
 
Table 9. Reduction on severity on second behavior given reduction on severity on first behavior by race; 
 30% reduction in smoking and a .3 SD reduction in severity on diet and sun total behavior scores; 
Co-progression odds ratios from baseline to 24 months#. 
** p< .05. *** p< .001. 
a
 Odds of reduced severity on the second behavior given reduced severity on the first behavior; 
# Recruited in 1999 in the United States. 
  
 
Whites  
Proportion (n/total N) 
Confidence Interval 
Non-Whites 
Proportion (n/total N) 
Confidence Interval 
Sun Protection & Diet 
 
  
Participants who reduced severity on diet given reduced 
severity on unprotected sun exposure 
.45 (658/1474) 
[.42, .48] 
 
.39 (26/67) 
[.27, .51] 
Participants who reduced severity on diet given no 
reduced severity on unprotected sun exposure 
.39 (575/1484) 
[.37, .41] 
 
.39 (25/65) 
[.27, .51] 
 
Co-progression odds ratioa 
 
1.28***(1.10, 1.48) 
 
1.02 (0.50, 2.05) 
Smoking & Diet 
 
  
Participants who reduced severity on diet given reduced 
severity on smoking 
.44 (130/298) 
[.38, .50] 
 
.36 (5/14) 
[.11, .61] 
Participants who reduced severity on diet given no 
reduced severity on smoking 
.36 (212/583) 
[.32, .40] 
 
.26 (7/27) 
[.09, .42] 
 
Co-progression odds ratioa 
 
1.35** (1.02, 1.80) 
 
1.59 (0.40, 6.38) 
Smoking & Sun Protection 
 
  
Participants who reduced severity on unprotected sun 
exposure given reduced severity on smoking 
.53 (156/296) 
[.47, .59] 
 
.50 (6/12) 
[.22, .78] 
Participants who reduced severity on unprotected sun 
exposure given reduced severity on smoking 
.49 (298/609) 
[.45, .53] 
 
.48 (14/29) 
[.30, .66] 
 
Co-progression odds ratioa 
 
1.16 (0.88, 1.53) 
 
1.07 (0.28, 4.12) 
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Table 10 presents the participants who progressed to criteria and the co-
progression odds ratios for reduction on severity for each behavior pair from baseline to 
24-month follow-up by gender.  Specifically, Table 10 presents the participants and odds 
of reduction on severity on the second behavior given reduction on severity on the first 
behavior compared to the reduction on severity on the second behavior and no reduction 
on severity on the first behavior from baseline to 24-month follow-up for males and 
females.   
Sun Protection and Diet  
Results were significant for males, OR= 1.24 [1.00, 1.55], p < .053, and females, 
OR= 1.27 [1.05, 1.54], p < .013, indicating that both sexes were more likely to reduce 
severity on diet given reduced severity on sun protection compared to reducing severity 
on diet alone.  Specifically, males were just under and females were just over one and a 
quarter times more likely to reduce severity on diet and sun protection compared to 
reducing severity on diet alone.    
Smoking and Diet  
Results were not significant for males, OR= 1.29 [0.80, 2.10], p < .303, indicating 
that although males were more likely to reduce severity on diet given reduced severity on 
smoking compared to males who reduced severity on diet alone, the difference within the 
group was not reliable.  In contrast, results were significant for females, OR= 1.41 [1.00, 
1.99], p < .048, indicating that females were almost one and a half times more likely to 
reduce severity on diet given reduced severity on smoking compared to females who 
reduced severity on diet alone.   
Smoking and Sun Protection 
 61 
 
Results were not significant for males, OR= 1.23 [0.78, 1.95], p < .371, or 
females, OR= 1.11 [0.79, 1.56], p < .534, indicating that although each sex was more 
likely to reduce severity on sun protection given reduced severity on smoking compared 
to their cohort who reduced severity on sun protection alone, the differences within each 
cohort were not reliable.     
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Table 10. Reduction on severity on second behavior given reduction of severity on first behavior by gender; 
 30% reduction in smoking and a .3 SD reduction in severity on diet and sun total behavior scores; 
Co-progression odds ratios from baseline to 24 months#. 
** p< .05. *** p< .001. 
a
 Odds of reduced severity on the second behavior given reduced severity on the first behavior; 
# Recruited in 1999 in the United States. 
 
  
 
Males 
Proportion (n/total N) 
Confidence Interval 
Females 
Proportion (n/total N) 
Confidence Interval 
Sun Protection & Diet 
 
  
Participants who reduced severity on diet given reduced 
severity on unprotected sun exposure 
.44 (286/649) 
[.40, .48] 
 
.45 (398/894) 
[.42, .48] 
Participants who reduced severity on diet given no 
reduced severity on unprotected sun exposure 
.39 (260/670) 
[.35, .43] 
 
.39 (340/879) 
[.36, .42] 
 
Co-progression odds ratioa 
 
1.24** (1.00, 1.55) 
 
1.27**  (1.05, 1.54) 
Smoking & Diet 
 
  
Participants who reduced severity on diet given reduced 
severity on smoking 
.41 (45/110) 
[.32, .50] 
 
.45 (90/202) 
[.38, .52] 
Participants who reduced severity on diet given no 
reduced severity on smoking 
.35 (70/200) 
[.28, .42] 
 
.36 (149/411) 
[.31, .41] 
 
Co-progression odds ratioa 
 
1.29 (0.80, 2.10)  
 
1.41**  (1.00, 1.99) 
Smoking & Sun Protection 
 
  
Participants who reduced severity on unprotected sun 
exposure given reduced severity on smoking 
.50 (54/109) 
[.40, .60] 
 
.54 (108/199) 
[.47, .61] 
Participants who reduced severity on unprotected sun 
exposure given reduced severity on smoking 
.44 (102/230) 
[.38, .50] 
 
.52 (211/409) 
[.47, .57] 
 
Co-progression odds ratioa 
 
1.23 (0.78, 1.95) 
 
1.11 (0.79, 1.56) 
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Decisional Balance (DB) (i.e., H4) by race and gender 
Table 11 presents the participants who progressed to criteria and the co-
progression odds ratios for participants who increased their Pros .4 SD on the second 
behavior given a .4 SD increase on Pros on the first behavior compared to participants 
who increased their Pros .4 SD on the second behavior but did not increase their Pros .4 
SD on the first behavior from baseline to 24-month follow-up for Whites and Non-
Whites.   
Sun Protection and Diet 
Results were significant for Whites, OR= 1.34 [1.10, 1.63], p < .004, indicating 
that Whites were more than one and a third times more likely to increase their Pros on 
diet by .4 SD given a .4 SD increase on sun protection compared to Whites who only 
increased their Pros .4 SD on diet alone.  In contrast, results were not significant for Non-
Whites, OR= 1.83 [0.85, 3.96], p < .125, indicating that although Non-Whites were 
almost two times more likely to increase their Pros .4 SD on diet given a .4 SD on sun 
protection compared to Non-Whites who increased their Pros .4 SD on diet alone, the 
difference within the comparison groups was not reliable.   
Smoking and Diet  
Results were not significant for Whites, OR= 1.24 [0.86, 1.81], p < .249, 
indicating that although Whites were slightly more likely to increase Pros .4 SD on diet 
given a .4 SD increase on Pros on smoking compared to Whites who made a .4 SD 
increase on diet alone, the difference within this group was not reliable.  In contrast, 
results were significant for Non-Whites, OR= 6.13 [1.46, 25.72], p < .013, indicating that 
Non-Whites were over six times more likely to increase their Pros .4 SD on diet given a 
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.4 SD increase on Pros on smoking compared to Non-Whites who increased their Pros .4 
SD on diet alone. 
Smoking and Sun Protection 
Results were significant for Whites, OR= 1.47 [1.05, 2.06], p < .025, indicating 
that Whites were almost one and half times more likely to increase their Pros .4 SD on 
sun protection given a .4 SD increase on Pros on smoking compared to Whites who only 
increased their Pros .4 SD on sun protection alone.  In contrast, results were not 
significant for Non-Whites, OR= 1.43 [0.37, 5.55], p < .606, indicating that although 
Non-Whites were almost one and a half times more likely to increase Pros .4 SD on sun 
protection given a .4 SD increased Pros on smoking compared to Non-Whites who 
increased their Pros by .4 SD on sun protection alone, the difference within Non-Whites 
was not reliable.     
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Table 11. .4 SD Pros increase on second behavior given .4 SD Pros increase on first behavior by race; 
Co-progression odds ratios from baseline to 24 months#. 
** p< .05. *** p< .001. 
a
 
a
 Odds of increasing Pros .4 SD on second behavior given .4 SD increase on Pros on the first behavior; 
# Recruited in 1999 in the United States. 
  
 
Whites 
Proportion (n/total N) 
Confidence Interval 
Non-Whites 
Proportion (n/total N) 
Confidence Interval 
Sun Protection & Diet 
 
  
Participants who increased Pros .4 SD on diet given 
a .4 SD increase on Pros for sun protection 
.24 (184/759) 
[.18, .30] 
.38 (18/48) 
[.24, .51] 
 
Participants who increased Pros .4 SD on diet given 
no .4 SD increase on Pros for sun protection 
.19 (398/2063) 
[.18, .21] 
 
.25 (20/81) 
[.15, .34] 
 
Co-progression odds ratioa 
1.34**  (1.10, 1.63) 1.83 (0.85, 3.96) 
Smoking & Diet 
 
  
Participants who increased Pros .4 SD on diet given 
a .4 SD increase on Pros for smoking 
.24 (50/212) 
[.18, .29] 
 
.57 (8/14) 
[.31, .83] 
Participants who increased Pros .4 SD on diet given 
no .4 SD increase on Pros for smoking 
.20 (127/639) 
[.17, .23] 
 
.18 (5/28) 
[.04, .32] 
 
Co-progression odds ratioa 
1.24 (0.86, 1.81) 6.13**  (1.46, 25.72) 
Smoking & Sun Protection 
 
  
Participants who increased Pros .4 SD on sun 
protection given a .4 SD increase on Pros for 
smoking 
.32 (68/213) 
[.26, .38] 
 
.42 (5/12) 
[.14, .70] 
Participants who increased Pros .4 SD on sun 
protection given no .4 SD increase on Pros on 
smoking 
.24 (166/687) 
[.21, .27] 
 
.33 (11/33) 
[.17, .49] 
 
Co-progression odds ratioa 
 
1.47 (1.05, 2.06) 
 
1.43 (0.37, 5.55) 
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Table 12 presents the participants who progressed to criteria and the co-
progression odds ratios for participants who increased their Pros by .4 SD on the second 
behavior given a .4 SD increase on Pros on the first behavior compared to participants 
who increased their Pros .4 SD on the second behavior but did not increase their Pros .4 
SD on the first behavior from baseline to 24-month follow-up for males and females. 
Sun Protection and Diet  
Results were not significant for males, OR= 1.20 [0.89, 1.63], p < .238, indicating 
that although males were slightly more likely to increase their Pros .4 SD on diet given a 
.4 SD increase on Pros on sun protection compared to males who made a .4 SD increase 
on diet alone, the difference within the White comparison group was not reliable.  In 
contrast, results were significant for females, OR=1.50 [1.18, 1.93], p < .001, indicating 
that females were one and a half times more likely to increase their Pros .4 SD on diet 
given a .4 SD increased Pros on sun protection compared to females who increased their 
Pros .4 SD on diet alone.   
Smoking and Diet  
Results were not significant for males, OR= 1.19 [0.64, 2.21], p < .576, or 
females, OR=1.50 [0.98, 2.31], p < .065, indicating that although both sexes were more 
likely to increase their Pros on diet .4 SD given a .4 SD increased Pros on smoking 
compared to their cohort who increased their Pros .4 SD on diet alone, the differences 
within each comparison group was not reliable.   
Smoking and Sun Protection 
Results were not significant for males, OR= 1.41 [0.80, 2.46], p < .232, indicating 
that although males were almost one and a half times more likely to increase their Pros .4 
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SD on sun protection given a .4 SD increase on Pros on smoking compared to males who 
increased their Pros .4 SD on sun protection alone, the difference within the male cohort 
was not reliable.  In contrast, results were significant for females, OR= 1.50 [1.00, 2.24], 
p < .049, indicating that females were one and a half times more likely to increase their 
Pros .4 SD on sun protection given a .4 SD increased Pros on smoking compared to 
females who increased their Pros .4 SD on sun protection alone.     
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Table 12. .4 SD Pros increase on second behavior given .4 SD Pros increase on first behavior by gender; 
Co-progression odds ratios from baseline to 24 months#. 
** p< .05. *** p< .001. 
a
 
a
 Odds of increasing Pros .4 SD on second behavior given .4 SD increase on Pros on the first behavior; 
# Recruited in 1999 in the United States. 
 
  
 
Males 
Proportion (n/total N) 
Confidence Interval 
Females 
Proportion (n/total N) 
Confidence Interval 
Sun Protection & Diet 
 
  
Participants who increased Pros .4 SD on diet given 
a .4 SD increase on Pros for sun protection 
.22 (74/340) 
[.17, .26] 
 
.27 (128/468) 
[.23, .31] 
Participants who increased Pros .4 SD on diet given 
no .4 SD increase on Pros for sun protection 
.19 (175/931) 
[.16, .21] 
 
.20 (243/1214) 
[.18, .22] 
 
Co-progression odds ratioa 
 
1.20 (0.89, 1.63) 
 
1.50*** (1.18, 1.93) 
Smoking & Diet 
 
  
Participants who increased Pros .4 SD on diet given 
a .4 SD increase on Pros for smoking 
.23 (18/78) 
[.14, .32] 
 
.27 (40/149) 
[.20, .34] 
Participants who increased Pros .4 SD on diet given 
no .4 SD increase on Pros for smoking 
.20 (45/224) 
[.15, .25] 
 
.20 (87/443) 
[.16, .23] 
 
Co-progression odds ratioa 
 
1.19 (0.64, 2.21) 
 
1.50 (0.98, 2.31) 
Smoking & Sun Protection 
 
  
Participants who increased Pros .4 SD on sun 
protection given a .4 SD increase on Pros for 
smoking 
.29 (24/82) 
[.19, .39] 
 
.34 (49/144) 
[.30, .40] 
Participants who increased Pros .4 SD on sun 
protection given no .4 SD increase on Pros on 
smoking 
.23 (58/255) 
[.18, .28] 
 
.26 (119/465) 
[.21, .30] 
 
 
Co-progression odds ratioa 
 
1.41 (0.80, 2.46) 
 
1.50** (1.00, 2.24) 
 69 
 
CHAPTER 5 
CONCLUSIONS 
Discussion 
Results provide empirical support for the advantages of simultaneous multiple 
health behavior change for three very different health behaviors.  Specifically, when 
smoking, diet, and unprotected sun exposure were analyzed as the three sets of behavior 
pairs sun protection and diet, smoking and diet, and smoking and sun protection, results 
consistently demonstrated that intervening simultaneously on multiple health behavior 
risks increased the likelihood that participants progressed toward healthier outcome 
criteria on both behaviors from baseline to 24-month follow-up compared to participants 
who only progressed on the second behavior in the behavior pair from baseline to 24-
month follow-up.  Of particular importance is that, as expected, favorable results 
occurred across the control, treatment, and total conditions.  Moreover, favorable results 
were revealed when the outcome was defined by less stringent as well as the most 
stringent criteria.  That is, when treatment outcomes were defined by stage progress, 
reduction in severity, and increased Pros (i.e., less stringent) or defined by meeting 
Action/Maintenance (i.e., A/M) criteria (i.e., the most stringent) on both behaviors at 24-
month follow-up, results consistently demonstrated that simultaneous intervention 
increased the likelihood that participants progressed on both behaviors compared to only 
making progress only on the second behavior from baseline to 24-month follow-up.  
The first hypothesis was supported.  The clearest and strongest support occurred 
in the sun protection and diet behavior pair analyses which revealed significant and 
increased odds ratios in all three conditions.  A more modest finding was in the smoking 
and sun protection behavior pair analyses which revealed significant and increased odds 
 70 
 
ratios in the overall condition.  Although the treatment and control conditions in the 
smoking and sun protection behavior pair analyses were not significant, also the case for 
all three conditions in the smoking and diet behavior pair analyses, it is worth noting that 
all the odds ratios revealed were in the expected and favorable direction.  That is, all eight 
of the paired action odds ratios demonstrated that participants in later versus earlier SOC 
were more likely to progress to A/M on both behaviors compared to progressing to A/M 
only the second behavior at 24-month follow-up regardless of the treatment condition.  
Additionally, four of the eight results were significant.  Thus, the combination of 
significant findings and consistent pattern of results in both expected and favorable 
directions of the non significant findings lends support to hypothesis one.  More 
specifically, analyses clearly show that participants in later SOC (i.e., C/PR) at baseline 
for multiple health behavior risks were more likely to move to A/M on both behaviors at 
24-month follow-up than participants who were in the earliest SOC (i.e., PC) for both 
behaviors at baseline. 
The second hypothesis was generally supported.  The strongest support occurred 
in the sun protection and diet behavior pair analyses which revealed significant and 
higher co-progression odds ratios in the treatment and overall conditions.  Specifically, 
findings revealed that participants in the treatment condition were almost two times more 
likely to make stage progress on diet given stage progress on sun protection compared to 
participants who only made stage progress on diet.  In the smoking and diet behavior pair 
analyses, participants in the control group were approximately one a half times more 
likely to make stage progress on diet given stage progress on smoking while the treatment 
group was not significant; a significant finding in the control condition and not in the 
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treatment condition provides partial support to this hypothesis.  However, modest support 
for hypothesis two was found in the smoking and sun protection behavior pair analyses in 
that there were higher odds ratios in the treatment versus control condition for 
participants to make stage progress on sun protection given stage progress on smoking.  
Ultimately, all nine of the co-progression odds ratios demonstrated that participants were 
more likely to make stage progress on both behaviors compared to making stage progress 
only on the second behavior from baseline to 24-month follow-up regardless of the 
treatment condition.  Additionally, four of the nine results were significant.  Thus, the 
significant findings and general pattern of results in both expected and favorable 
directions of the non-significant findings lends support for hypothesis two.  More 
specifically, results clearly provide empirical support for the advantages of co-
progression and defining treatment outcome as stage progress from baseline to 24-month 
follow-up, a less stringent criterion than paired action defined in hypothesis one.   
The third hypothesis was supported.  The strongest support occurred in the sun 
protection and diet behavior pair analyses with significant results in the total and 
treatment conditions, indicating increased likelihood of a reduction on severity on both 
sun protection and diet compared to a reduction on severity on diet alone.  Significant 
results in the total and control conditions for the smoking and diet behavior pair analyses 
indicated that participants were just under and over one and a half times more likely to 
reduce severity on both smoking and diet compared to a reduction of severity on diet 
alone.  Ultimately, eight of the nine co-progression odds ratios demonstrated that 
participants were more likely to reduce severity on both behaviors compared to reduced 
severity only on the second behavior from baseline to 24-month follow-up regardless of 
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the treatment condition.  Additionally, four of the nine results were significant.  Of note, 
the only reduced likelihood of progressing on both behaviors compared to the second 
behavior was a slightly reduced likelihood and it was not significant.  Thus, results 
provide empirical support for using reduction in severity as an outcome criterion for 
treatment, corroborating reduction in severity as one of the four factors.  Furthermore, 
and similar to previous findings with MI intervention, results also show that reduction in 
severity can be predictive of behavior change at future follow-up time points.  Therefore, 
in addition to holding treatment outcomes to the most stringent criteria (i.e., A/M) 
typically used to establish intervention efficacy and effectiveness, these data suggest that 
reduction in severity may be especially important for multiple health behavior change 
given the well established difficulty of changing one health risk behavior to A/M criteria, 
let alone the difficulty of changing multiple health behavior risks to A/M criteria at the 
same time.  
The fourth hypothesis was generally supported.  Although the first set of planned 
analyses proved to be too stringent a criteria to complete as planned, the revised 
decisional balance (DB) criteria provided an empirical basis to evaluate the 
interrelationships of the Pros of behavior change and multiple behavior change.  That is, 
increasing Pros by .4 SD from baseline to 24-month follow-up on either or both 
behaviors yielded several significant results across the control, treatment, and total 
conditions.  Specifically, all nine of the co-progression odds ratios were in the predicted 
and favorable direction revealing increased likelihood of progressing on both behaviors 
compared to progressing only on the second behavior regardless of treatment condition.  
Additionally, five of the nine results were significant.  This is important because it clearly 
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shows that the Pros of DB, long established as important for single health risk behavior 
change, is also important to multiple health behavior change.  With five significant and 
all nine odds ratios all three behavior pairs and treatment conditions, results further 
suggest that dynamic variables are critical to the process of multiple health behavior 
change.  However, additional research is necessary in order to clarify just how the Pros of 
behavior change relates to multiple behavior change, and to begin to reveal how 
decisional balance (i.e., Pros and Cons) relates to multiple health behavior change.    
The fifth hypothesis was generally supported and answered by the analyses and 
results of hypothesis one through hypothesis four.   
The sixth hypothesis was generally supported.  For the stage progress with race 
and gender analyses, eight of the twelve results were not significant.  Of the significant 
findings, there was one for males, one for females, two for Whites, and none for Non-
Whites.  Therefore, there was no clear trend in the data.  For the reduction in severity 
with race and gender analyses, seven out of the twelve analyses were not significant.  Of 
the significant findings, there was one for males, two for females, two for Whites and 
none for Non-Whites.  Again, there was no clear trend in the data.  For the Pros with race 
and gender analyses, eight out of the twelve results were not significant.  Similarly, there 
was no clear trend in the data.  Altogether, twenty three out of the thirty six analyses (i.e., 
almost two-thirds) of the results were not significant and of the significant findings, there 
was no clear trend in the data as results varied by race, gender and treatment condition.  
However, further generalization of these results is limited given the demographic 
composition of this dataset as discussed in the limitation section.  So, as hypothesized, 
results did not yield significant differences between race or gender with regard to 
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multiple health behavior change whether outcome criteria was defined as paired action or 
co-progression from baseline to 24-month follow-up.   
Overall, in absolute terms, although there was one more significant finding across 
the control conditions compared to the treatment conditions, this research does not 
support either condition’s advantage.  Taken together, what these results do clearly 
suggest is that there are important advantages to simultaneous intervention for multiple 
health behavior change whether the intervention is stage-based, computer-tailored 
intervention or treatment as usual (TAU) as simultaneous intervention on multiple health 
risk behavior accelerated participants toward healthy criteria at outcome regardless of 
intervention.  However, given SOC and DB are central constructs to the TTM, it seems 
the TTM may have a slight advantage in helping to elucidate the science of multiple 
health behavior as the model has several dynamic variables which seem relevant to reveal 
the interrelationships and synergy that occurs during multiple health behavior change; 
although additional research is needed before any firm conclusions can be drawn.    
Results of this research recognize that although demographic variables are 
important factors to baseline SOC for various health risk behaviors, they are not reliable 
predictors of treatment outcome.  However, results do provide additional support that the 
dynamic variables of SOC, problem severity, and the Pros of DB are reliable predictors 
of treatment outcome and that they are important to multiple health behavior change.  As 
such, this research provides additional support to three of the four factors specifically 
(e.g., baseline SOC, DB, and addiction severity) and lends some support to the fourth 
factor (i.e., effort) as measured all participants analyzed in this study completed 
requirements over a two and a half year time period.  What is particularly compelling 
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about these results, however, is that the original four factors findings were revealed when 
the fundamental unit of analysis was separate health risk behaviors at outcome and these 
results were revealed when the fundamental unit of analysis was shifted to behavior pairs 
from baseline to 24-month follow-up.   
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Limitations 
There were several limitations of this research.  First, this was a secondary data 
analysis and, therefore, all analyses were limited to the existing dataset and its 
composition.  Although the primary aim of the P01 used for this research project 
intervened simultaneously on multiple health behavior risks, making it an ideal dataset to 
answer the stated hypotheses, analyzing behavior pairs and calculating paired action and 
co-progression odds ratios among treatment, control, and total conditions was not the 
primary aim of the original project.  Therefore, while analyses compared differences 
between treatment and control conditions, conclusions cannot be drawn directly 
comparing the two groups to one another.  That is, all comparisons in this research 
describe the likelihood of participants making progress as defined by outcome criteria 
(i.e., paired action or co-progression) that occurred in each treatment condition and not 
compared to each treatment condition.     
 Second, the predominantly White (n=8,503, 93.7%), female (n=5,938, 65.4%), 
middle-aged recruitment solely from a Northeastern state presents certain limitations as 
well.  For example, with race, such a large sample of Whites likely provided sufficient 
power to find significant differences in the analyses between Whites who met criteria 
(i.e., progressed on the second behavior given progress on the first behavior) compared to 
Whites who did not (i.e., who only made progress on the second behavior) versus Non-
Whites which had a very small sample size.  So, this may help explain why the sun 
protection and diet and the smoke and diet analyses was significant for Whites, but not 
significant for Non-Whites because there would have to be a very large effect size in 
order for the analyses to detect a significant difference in the Non-Whites group.  Also, 
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and consistent with the literature that race affects baseline SOC for health risk behaviors, 
race may also have affected all the analyses involving sun protection.  Specifically, fairer 
skin Whites, who are at greater risk for unprotected sun exposure than darker skin 
Whites, may have a different baseline SOC from one another.  Similarly, Non-Whites, 
who are at lower risk of unprotected sun exposure, may have a different SOC due to the 
reduced risk on this behavior.  Moreover, with such a small sample sizes for Non-Whites, 
this research recoded race as Whites and Non-Whites, an amalgamation of all Non-White 
races, ignoring important and possible variability between and within each group, 
respectively.   
Third, the sample size mean age was 43-years-old with a standard deviation of ten 
years.  Therefore, 68% of the sample ranged from 33 to 53-years-old and 96% of the 
sample ranged from 23 to 63-years-old.  Given the physical, cognitive, and social 
differences between middle-aged adults and other age groups, it is unclear how these 
results generalize to other populations and demographics.  For example, it is unclear how 
the normative stressors associated with middle adulthood (e.g., balancing marriage, 
parenting, family, career, finances, aging parents, etc.), quite distinct from other 
developmental stages (e.g., childhood, adolescence, late adulthood, very old age), may 
affect the processes of change for multiple health behavior change.  That is, it is not clear 
how reduced harm or the Pros of behavior change may vary by lifespan development.   
Fourth, all the participants were recruited from a Northeastern state.  As such, 
results may not generalize to other regions of the country given possible geographic 
differences with other parts of the country.  Another limitation of sample’s recruitment is 
that the Northeast has considerable seasonal variability and it is not clear how this may 
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have affected baseline and follow-up SOC for unprotected sun exposure.  Specifically, 
the summer has a higher risk of unprotected sun exposure for all races and both genders, 
but more so for Whites than Non-Whites, while the winter has a much lower risk for all 
races and both genders.  This temporal dimension was not accounted for by the analyses 
conducted in this research.  Therefore, its effect is unknown.   
There were several other limitations to this project as well.  The inability to 
complete all the planned analyses due to insufficient sample size and stringent criteria for 
the strong and weak principles for the behavior pairs obviated the opportunity to conduct 
analyses on decisional balance or the strong and weak principles for behavior pairs as has 
been established for separate behaviors.  Therefore, this project did not address these 
important gaps in the literature.  In addition, because of the cumulative nature of some of 
the hypotheses, some of the analyses were not able to be performed throughout the 
project as observed in the strong and weak principles for race and gender (i.e., hypothesis 
six).  Another limitation is that decisional balance measure (i.e., the Pros and Cons) for 
sun exposure was a 20-item Likert-scale.  However, decisional balance for smoking and 
diet were both assessed on a 5-item Likert-scale.  Although this was accounted for in 
calculating the mean and standard deviations for each behavior in each of the treatment 
conditions, it is not clear how a 20-item Likert-scale for sun exposure and two 5-item 
Likert scales for smoking and diet may have affected participants’ responses. 
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Summary 
Results provide empirical support for the advantages of simultaneous intervention 
for multiple health behavior change as paired action, co-progression, and reduction in 
severity was observed across the control, treatment and total conditions.  With 
approximately an equal amount of significant findings across the control and treatment 
conditions for paired action, co-progression, and reduction on severity, results do not 
support either condition’s advantage.  However, taken together, results do provide 
empirical support for the advantages and synergistic effect when intervening on multiple 
health behavior risks simultaneously, in addition to demonstrating the importance and 
value of the most stringent (i.e., A/M) as well as less stringent (i.e., stage progress, 
reduction of severity) outcome criteria when elucidating the science of behavior change.   
Results further suggest that simultaneous intervention targeting multiple health 
behavior risks for three very different behaviors increases the likelihood that participants 
will accelerate stage progress toward healthier behavioral lifestyles, including smoking 
cessation, healthy diet, and reduced risk for unprotected sun exposure.  Results of this 
research do not suggest that simultaneous intervention on multiple health behavior risks 
is too taxing, stressful, or difficult which would have been revealed with paired action or 
co-progression odds ratios lower than 1.0 in any of the behavior pair analyses across any 
of the treatment conditions.  In fact, only one out of the 71 odds ratios revealed a lower 
likelihood of progressing toward favorable and healthier outcome criteria whether in the 
most or less stringent outcome criteria analyses.  Specifically, the only exception was an 
odds ratio of .94 for the smoking and diet behavior pair analyses in the treatment 
condition for reduction in severity; however, this odds ratio was not significant.  Finally, 
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results do provide empirical support for shifting the fundamental unit of analysis from 
separate behaviors at outcome to behavior pairs at outcome.  
Recommendations for future research include efficacy trials to systematically 
evaluate the difference between treatment-enhanced and naturally occurring paired action 
and co-progression.  Research could also broaden the behavior pairs of analysis to 
investigate many other problem areas which bear directly on mortality, quality of life and 
health care costs.  Although numerous examples abound, one specific example would be 
to further understand the intricacies and interrelationships between medication adherence, 
diet, exercise, and substance abuse (e.g., smoking, alcohol) with diabetics.  Such 
advancements could provide invaluable information to help advance, inform, and guide 
integrated treatment as well as prevention research.  Of course, this is just a few of the 
behavior pair analyses that could help provide valuable contributions to the management, 
treatment, and prevention of many other chronic medical conditions such as 
cardiovascular disease and some cancers.  With countless other examples critical to 
issues of quality of life, disease management and prevention, healthcare costs, and public 
policy, continued research on multiple health behavior change is of paramount 
importance.  Such efforts will not only help elucidate the science of behavior change, but 
will also help guide the future of research and practice toward an integrative model of 
multiple health behavior change.  
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APPENDIX 
Appendix 1 
1) The original hypothesis, “participants who decrease their severity by a defined 
amount on one behavior (i.e., cutting back by a certain percentage of cigarettes per day) 
will also reduce their severity on other behaviors, with more co-progression observed in 
the treatment group than the control group” was slightly modified given data analytic 
problems.  Similar to previous analyses, the independent and dependent variables were 
analyzed by the same three behavior pairs: sun protection and diet, smoking and diet, and 
smoking and sun protection.  Specifically, the independent variable was the participant’s 
number of cigarettes smoked, diet total score, and sun protection total score at baseline 
and the dependent variable was whether the participant reduced their smoking habit by 
50% from baseline to 24-month follow-up, either yes or no, and whether they progressed 
to A/M on diet, either yes or no, and whether they progressed to A/M on sun protection, 
either yes or no, at 24-month follow-up.  Given so few participants (i.e., sometimes zero) 
met this criteria, analyses could not be completed as planned.  Therefore, this hypothesis 
was slightly revised and described and presented in hypothesis 3.   
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